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Abstract 
 
 With the ever-increasing complexity of spacecraft, the real-time data and state of 
health analysis by mission operators becomes an intricate process subject to the pitfalls of 
error-prone human reasoning techniques.  If even detected, characterizing an anomalous 
state on the spacecraft can take substantial amounts of time thus reducing overall 
operational efficiency and possibly even jeopardizing the mission.  This research 
specifically addresses the state-of-health analysis of biological payloads flown on NASA 
missions such as GeneSat-1 and PharmaSat.  The complex engineering systems and 
timely anomaly resolution required for maintaining life support in these biological 
spacecraft makes human diagnosis on its own insufficient.    
To address these challenges, this project incorporates the use of model-based 
reasoning for managing anomalies found on board biological microsatellites.  A 
spacecraft payload model was constructed with behaviors relevant to biological sample 
growth and the associated micro fluidic life support system.  A suite of algorithms was 
applied to the model for computing diagnosis conjectures on detected anomalies.  
Implemented in MATLAB/ Simulink and designed for use as a ground-based tool for 
human operators, this system focused primarily on mission operator decision support. 
The system was developed via analysis of GeneSat-1 flight data and with a 
biological test bed which emulated the growth characteristics of the spacecraft.  It was 
later integrated into the ground segment of the PharmaSat space system and verified with 
its flight data after launch.  Results gained from experimentation validated the tool’s 
ability to reason on unanticipated anomalies, its speed of analysis, and its ability to 
augment a human operator for real-time anomaly characterization and decision support.   
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 1
1 Introduction 
1.1 Motivation 
 
The value of any space mission is derived from the data products produced and 
services provided by the spacecraft.  Characteristics inherent to space flight such as a 
dynamic global view, location above the atmosphere, microgravity, and radiation 
environments allow the spacecraft to generate and disseminate unique data which can be 
exploited via commercial, civil, and military avenues [1].  For example, spacecraft are 
routinely used for global communications, imaging, navigation, solar system exploration, 
and in-situ experimentation.   
The primary appeal of a spacecraft is also its biggest drawback.  The extreme 
nature of the space environment and the long distances from which they operate impose 
rigorous design considerations and thus increase the complexity of these systems.  This 
raises the likelihood of anomalous behavior in the system ultimately warranting a method 
for detecting, diagnosing, and resolving these anomalies efficiently.  Additionally given 
that the spacecraft operates remotely, it is impossible to inspect it in person should an 
anomaly be detected; the ability for human operators to reason on the system’s well-
being is purely dependent on the data sent back [1, 2].   
Techniques aimed at timely anomaly management are usually procedural and 
involve large numbers of system experts who offer their invaluable insight.  However, 
since human reasoning techniques can be costly and error-prone, the result can be 
incomplete or incorrect resulting in a critical inefficiency in mission operations [1].  
Streamlining missions operations is paramount since they can account for 25-60% of total 
project costs. [3]  
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1.2 Reasoning Approaches 
In an effort to aid operators in the difficult task of accurately assessing the state of 
a spacecraft, a formalized reasoning theory of fault detection and diagnosis can be 
applied to streamline anomaly management.  One such theory is derived from the field of 
model-based reasoning (MBR).  In MBR, reasoning conjectures are computed from 
fundamental design knowledge of the engineering system.  This technique, which is often 
referred to as reasoning from first principles, relies on the use of a model that describes 
component or subsystem level behavior, interconnectivity, and performance.  Given 
certain constraints and inputs, this model can be used to simulate outputs that are 
expected from the real system.  The real system typically generates its outputs using 
sensors and telemetry.  Comparing the expected and actual outputs of any system is a 
common technique in MBR fault detection; any discrepancy between the two can be a 
potential anomaly within the system and is cause for deeper investigation.  
The investigative process of finding discrepancies in simulated and real data is 
called detection.  From there the user can compute diagnosis conjectures for anomalous 
components or subsystems. Taking this notion a step further, the system can be designed 
to change its state based on the diagnoses to either remedy the anomaly or minimize its 
effects.  This is known as resolution.  While the states from a model created for use with 
the MBR framework could be evaluated manually by a human, the timeliness and 
efficiency does not scale to even modestly large and complex systems.  Implementing 
model state evaluation as well as detection, diagnosis, and resolution on a computer can 
significantly reduce computation time.      
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Applications of MBR have been ubiquitous in a wide variety of engineering 
disciplines including aerospace, industrial design, biomedicine, and automotive design.  
Though the implementation of the technique is varied, many similarities exist between 
specific applications.  Since MBR relies on representing the behavior of the system 
through individual models of its components, system models are typically networks of 
interconnected components; each of which is assigned a ‘plant model’ equation.  This 
level of abstraction creates a common architecture which generally varies only by 
implementation and complexity.  For example, an MBR system which involves the 
circuit health analysis in avionics packages [4] once abstracted has many common 
elements as a more complex model-based automotive diagnostics package [5] involving 
hundreds of electrical, mechanical, and software- based components.  For example, once 
component-specific behaviors are captured, an integrated circuit’s truth table can be 
handled identically as the performance of an automobile’s adaptive suspension system. 
The use of MBR is a particularly interesting solution for the autonomy of 
interplanetary spacecraft.  A study conducted in 1995 between researchers at NASA’s Jet 
Propulsion Laboratory and Ames Research Center called NewMAAP (New Millennium 
Autonomy Architecture Prototype) applied MBR techniques to a simplified simulated 
model of the Cassini spacecraft, NASA’s most complicated spacecraft to date.  An aspect 
of this research focused on NewMAAP’s fuel system and thrusters; the system was able 
to dynamically adapt after detecting faulted fuel system components to deliver the 
necessary thrust in critical maneuvers such as an autonomous orbit insertion [6].  Figure 
1.1 shows a model of the NewMAAP fuel system.  NewMAAP’s application of MBR to 
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fluidic components on a spacecraft is of particular interest given the research presented in 
this thesis.   
 
Figure 1.1 – Simplified Schematic of Cassini Spacecraft Propulsion System – In this 
example, the circled valve is faulted resulting in actuation of the second thruster [6]   
 
The success of the NewMAAP research led to notable work pertaining to the 
Livingstone system flown on the NASA New Millennium Program’s Deep Space One 
(DS-1) mission [6, 7].  Launched in 1998 and retired in 2001, DS-1 was a flight test of 
numerous technologies including an ion propulsion engine, autonomous navigation and 
imaging (Autonav), and a remote agent responsible for onboard anomaly management.   
The Livingstone Remote Agent Experiment (RAX) demonstrated a new approach 
to spacecraft command and control.  By incorporating the autonomous remote agent into 
DS-1’s flight software, operators were able to rely on the agent to achieve particular 
goals.  Since the operators did not know the exact conditions on the spacecraft, they did 
not tell the agent exactly what to do.  Rather, using this model-based system they could 
specify what goals to achieve in a period of time as well as how and when to report back.  
Even in the event of an anomaly onboard the spacecraft, the remote agent would make a 
best effort to work around or resolve the anomaly to complete the goal set by operators.  
Figure 1.2 illustrates the architecture of the entire model-based system.   
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Figure 1.2 – Livingstone Architecture Diagram – The model shown in Figure 1.1 and 
the actual spacecraft are adapted into the Livingston architecture.  The controller uses 
each one’s states to compute which inputs are appropriate to achieve a given goal. [6] 
 
Another aerospace application of interest was the use of MBR on the fuel system 
of an F/A-18 Hornet fighter jet.  This work focused on using MBR on a system far more 
complex than most demonstration systems to model the fuel flow through the aircraft.  
The model incorporated 89 components in 13 subsystems and took a total of 3 years to 
reverse engineer.  Though not used in real-time flight scenarios, it was proven that even 
an exhaustively large model of fluidic components could be used for MBR applications 
[8].   Figure 1.3 illustrates the aircraft’s fuel system.     
 
Figure 1.3 – The F/A – 18 Fuel System – Illustrated here is the interconnectivity of the 
fighter’s main fuel system components.  Capturing the behavior of these components and 
their connections was the heart of the research project. [8]    
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Not only applicable in aerospace, MBR has been used in industrial control 
applications.  Of particular interest to this research are the applications involving control 
of biological processes.  These applications by definition have modeled their biological 
sample and can derive predicted states analogous with those measured in the real system 
to perform high level control tasks.  There has been extensive work in maximizing the 
manufactured volume of yeast, and a good example of this work is the automation of 
baker’s yeast production.  A model estimating the key state variables in the yeast’s 
bioprocesses guides the control algorithm for administering the maximum amount of 
glucose possible without negatively altering the yeast’s metabolism to achieve the most 
efficient growth [10]. Another example of MBR used in bioprocess control is the 
regulation of insulin dosage to diabetic patients.  Given input constraints such as the 
patient’s current state of health, time of day, types of meals eaten, etc. a model is 
generated with an expected amount of insulin required.  Compared to a measured blood 
glucose level the system reasons on the predicted and expected values and doses the 
patient accordingly.  Suggestions and diagnoses are offered to the user should there be an 
unexpected discrepancy in predicted and actual blood glucose values [11]. 
 
1.3 Objectives 
 
The objective of this work was to investigate the use of MBR techniques to 
increase mission operators’ awareness of a biological microsatellite’s state of health.  A 
spacecraft payload model was constructed with behaviors for biological sample growth 
and the associated micro fluidic life support system.  A suite of algorithms was applied to 
the model for computing diagnosis conjectures on detected anomalies and verified via 
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experimentation.  Implemented in the MATLAB/Simulink computational package and 
designed for use as an on-console tool, this system focused primarily on near real-time 
mission operator decision support. 
To the author’s knowledge this is the first ever opportunity to implement MBR as 
an anomaly management system for the biological payload of a spacecraft.  Additional 
objectives of this project were:   
• Integration of MBR with a real space system and mission operations 
ground segment, 
• Development of a representation of fluid flow modeling in between 
microfluidic components, 
• Creation of reasoning strategies to address time-based dynamic behaviors 
in MBR systems. 
 
1.4 Contributions 
 
In order to satisfy the objectives of this project and to motivate follow-on work, 
contributions made include the following: 
• Application and experimental verification of the MBR system in the 
context of the NASA PharmaSat mission, 
• Application of MBR modeling techniques to a new engineering system 
including microfluidic systems, 
• The extended development of graphical modeling tools and techniques 
which facilitate future MBR applications. 
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• A gained understanding of biological handling, preparation, and use in 
experimentation for future Santa Clara University space flight missions.  
 
1.5 Reader’s Guide 
 
 
This thesis is composed of 5 main chapters and subsequent appendices.  Chapter 1 
discusses the research project’s motivations, reasoning approaches, objectives, 
contributions and this reader’s guide.  Chapter 2 describes the GeneSat-1, PharmaSat, and 
biological test bed engineering systems with respect to the biological experiment that 
each one of these carries out.  The level of detail used is moderate but necessary because 
Chapter 3 discusses the modeling of these systems in greater detail.  This chapter also 
outlines the MBR technique and how it is applied to this decision support system.  
Chapter 4 presents experimental results and Chapter 5 gives a summary of the work done 
as well as conclusions and suggestions for future work. 
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2 Experimental System Design 
This chapter describes the primary test beds used during the research project.  
Included are descriptions of the GeneSat-1 and PharmaSat satellites along with a 
prototype biological test bed used for bench testing.  GeneSat-1’s flight experiment data 
was used to refine the research project’s modeling and design approaches while 
PharmaSat was still under development.  After PharmaSat’s successful launch its 
experimental data was used as a primary means of verification of the anomaly 
management tool.  Since injecting anomalies into PharmaSat to test the tool was not 
possible, a ground-based biological test bed was developed to facilitate testing and 
diagnosis verification. The research in this thesis is focused primarily on the anomaly 
detection and diagnosis of the biological payloads of these systems which includes 
modeling of their functionality; hence, an overview of the functionality of these systems 
is presented here. 
 
2.1  GeneSat-1   
 The Genesat-1 (Figure 2.1) technology demonstration mission validated the use of 
research quality instrumentation for in situ biological research and processing in a space 
environment. After its launch on December 16, 2006 all primary science and engineering 
test objectives were successfully tested after one month of operation [15].  The data 
products from the GeneSat-1 mission were used in this research project to facilitate initial 
biological and microfluidic modeling which is presented in Chapters 3 and 4. 
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The GeneSat-1 Microsatellite and the P-
POD deployment device 
 
The GeneSat-1 mission patch 
Figure 2.1 – GeneSat-1 
 
2.1.1 Mission Overview 
The GeneSat-1 mission was the first microsatellite to incubate living bacteria in a 
microgravity environment.  The study involved observing the growth of E. coli (a 
common and well-understood laboratory strain bacteria) over the course of 96 hours.  The 
bacteria were provided nutrients, a steady heat source, and humidified oxygen in a sealed 
container in the spacecraft’s payload to enable growth.  After having determined the state 
of the satellite was appropriate (a stabilized attitude with an established microgravity 
environment), satellite operators issued the spacecraft a command to administer heat and 
nutrients to the biology.  Growth was autonomously monitored by the spacecraft and 
measurements were down linked by satellite operators over the course of the mission 
lifetime. 
The spacecraft also served as a technology demonstration aimed at establishing 
small satellites as a low-cost solution for biological research in space.  Many 
collaborators from local industry and academic institutions were involved in the 
development of various flight and mission systems.  Students from California Polytechnic 
State University, San Luis Obispo developed the P-POD deployment device which 
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protected the satellite during launch and ejected it into orbit once the appropriate altitude 
was reached.  Stanford University was involved in prototyping components of the 
biological payload and bus subsystems including optics, communications, and structural 
elements. Santa Clara University developed all mission operations subsystems for 
command, control, and data analysis of the spacecraft for on-orbit operations as well as 
providing a team of all student operators; a first for a NASA mission.   
 
2.1.2 Data Products 
With respect to the biology experiment, two main data products were produced: 
optical density and growth fluorescence measurements.  Both of these readings were 
taken using a set of custom optics devices – essentially an array of Light Emitting Diodes 
(LEDs) and corresponding detectors.  The experiment carried 12 such arrays, one for 
each 110µl well containing biology.  The data collected from the spacecraft was 
compared to a control experiment concurrently executed on the ground – thus the main 
variable in growth between the two could be likened to microgravity effects.    
The optical density measurement provided a quantitative representation of the 
well turbidity.  An LED was shone through an individual well and the amount of light 
coming through the other side was measured by the detector.  This meant that the 
quantity of light absorbed by the well could be correlated to a cell population count.  
Repeated measurements provided a growth curve of the bacteria over time.   
 The experiment also focused on measuring the bacteria’s metabolic rates by 
measuring its Green Fluorescence Protein (GFP).  When excited by an external UV light 
source, this genetically engineered protein produced an optically visible green light, the 
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brightness of which corresponded to a metabolic state thus indicating how well that 
specific cell was growing.  With enough cells glowing, the combined light in an 
individual well could also be captured by the detector.  The experimental flight data is 
shown in Figure 2.2. 
Other telemetry of interest included payload state-of-health and power 
management data.  Elements such as well plate temperatures, air pressure, and relative 
humidity values were essential in verifying that the environment the bacteria were  
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Figure 2.2 – 96 Hour Experiment Data – GeneSat-1 Flight Unit 
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growing in was optimal and corresponded to the control experiment on the ground.  
Maintaining the ideal temperature for bacteria growth required significant amounts of 
power to drive a heater located on the well plate. Budgeting power was therefore of great 
importance during the experiment leading to the constant monitoring of battery voltages 
and solar panel currents.  Power was also needed to drive the optics as well as other 
sensors in the payload subsystem, thus placing additional importance on these telemetry 
values.   
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Figure 2.3 – Experimental Support Telemetry – GeneSat-1 Flight Unit 
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The autonomous state-of-health monitoring of this payload telemetry as well as 
biological growth information during on-orbit operations for future heritage missions was 
the inspiration for this research project.  The author of this thesis served as a primary 
operator for the spacecraft, and it is through this experience that there arose a need to 
develop a system that could accurately detect and diagnose anomalies in near real-time 
based only on available telemetry.   The GeneSat-1 flight data was used in initial testing 
of system modeling and algorithm verification.  Being able to use the biological growth 
data as a form of feedback for nominal spacecraft health was invaluable in the creation of 
this decision support tool. 
 
2.2 PharmaSat 
 With the technology successfully validated in the GeneSat-1 mission, the follow-
on PharmaSat (Figure 2.4) experiment was immediately pursued.  Based on GeneSat-1’s 
heritage, a more complex PI driven biological experiment was developed to fly in the 
same chassis using essentially the same bus but with an almost entirely reworked (and 
more intricate) payload.  The increased complexity to accommodate the experiment 
resulted in the use of more components and consequently generated more telemetry.  This 
made an operator’s interpretation of the spacecraft’s condition in orbit more time-
consuming and prone to error.  This research project was aimed at reducing this 
reasoning time and aiding the operator’s understanding of the payload’s state-of-health.  
The PharmaSat system described in this chapter was modeled and the data downloaded 
after launch was used in an end-to-end verification of the anomaly management tool. 
 15
Successfully launched on May 19th 2009 from Wallops Island, VA, PharmaSat 
was a secondary payload aboard a Minotaur I rocket co-manifested with TacSat-3 
(developed by the Air Force Research Laboratory). Mission operations were conducted 
by the Robotic Systems Laboratory at Santa Clara University.  PharmaSat’s primary 
mission ended within a few weeks of launch when the experiment was complete and all 
pertinent data was downloaded from the spacecraft. 
 
 
Top – Assembled Unit W/O Solar Panel, Exposing 
Fluidics Valves.  Left – Payload Assembly.   
Right – Installed Payload Assembly. 
 
 
 
 
PharmaSat Mission Patch 
 
TacSat-3 and PharmaSat launch 
 Figure 2.4 – PharmaSat  
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2.2.1 Mission Overview 
 The PharmaSat experiment and flight system was designed to measure the 
influence of microgravity on yeast resistance to an antifungal agent.  The PI-led science 
ultimately focused on determining the quantity of antifungal drugs needed to be 
administered to humans who develop a yeast infection on long-term space flights, a 
commonly reoccurring illness. 
 The self-contained and autonomous nanosatellite featured tri-color optical 
detectors, an intricate microfluidic network, environmental control, and power 
management subsystems.  Flying these additional components in the same size package 
required advances in miniaturization and integration strategies.  The experiment was 
designed to be executed the same way as GeneSat-1; with orbit stability and microgravity 
environment conditions to be met before execution.  The spacecraft autonomously 
maintained and recirculated the payload fluids at 5°C (to prevent freezing in orbit) until 
the ‘Start Experiment’ command was received, after which it administered a growth 
media to the yeast, prepared three different concentrations of antifungal solution, and 
after a period of about 40 hours delivered the antifungal to the yeast which had reached a 
scientifically critical point in its growth curve.  Like with GeneSat-1, the data was sent 
back to Earth where Santa Clara University student operators were on console evaluating 
the spacecraft’s state of health as commands were being sent. 
 
2.2.2 Biology Experiment 
While similar to GeneSat-1’s biological experiment on a high level, PharmaSat 
not only incubated its fungus specimen for the duration of the flight, but also challenged 
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its resistance to different concentrations of a drug created to treat that specific strain.  
Much like the E. coli bacteria flown on GeneSat-1, the Saccharomyces cerevisiae strain 
of budding yeast is a fundamentally well-understood laboratory specimen common to 
biological research, making it a good selection for this mission.   
The well plate containing biology was divided into five rows, each containing 12 
wells for a total of 60 wells. One row was used as an optical calibration baseline and was 
not administered any media.  The other four were grown simultaneously.  One row acted 
as a control (no antifungal), and the other three were given low, medium, and high 
concentrations of the pharmacological drug.  Each well had two 1 µm filters on the input 
and output channels to allow media to flow through while keeping the biology in the 
wells.  Figure 2.5 illustrates the custom well plate. 
 
 
Figure 2.5 – PharmaSat Well Plate Illustrating the 5 Biology Well Banks 
 
The experiment execution was broken down into two subsystems, Payload and 
Fluidics; each of which was divided into phases that commenced only after the conditions 
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of the previous phase had been satisfactorily reached or a timeout had occurred.  Each 
subsystem was driven by its own PIC 18F microprocessor and consequently its own state 
machine though both were synchronized to work together.  There were a total of 7 such 
phases in the payload identified with standard letters, and 12 phases in the fluidics 
identified with roman numerals.  An overview of the phases of both subsystems can be 
seen in Figure 2.6. 
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Figure 2.6 – PharmaSat Experimental Phases – Payload and Fluidics 
 
 
Phase A was initiated shortly after deployment of the spacecraft from the P-POD 
and involved collecting health and status data for a maximum of 15 days as the spacecraft 
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stabilized.  The fluidics system circulated growth media in phase I with the payload 
maintaining a keep-alive heater setting at 5°C to prevent the fluid from freezing.  When 
mission management, engineers, and operators determined that the spacecraft had 
stabilized, was healthy, and had achieved a microgravity environment, phase B 
commenced with the heating of the fluidics to 19 °C via an explicit command sent from 
the ground.  The delayed fluid heating was done so as to save power, but was necessary 
to avoid cold-shocking the yeast when the media was administered later in the 
experiment.  A heat stability flag was set for the fluidics once the set point temperature 
was reached.  Upon the setting of this flag the payload controller activated the card heater 
to maintain the temperature of the yeast at 27 ± .5°C.  A subsequent card heat stability 
flag triggered the fluidics controller to administer growth media to the yeast (Phase D1/ 
III).  In the 40 hours that the yeast cells were actively growing, the fluidics system phases 
IV-VI prepared the high and low concentrations of antifungal to be administered.  
 The second half of the experiment (D2, D3, and E) started by dosing the control 
bank with growth media and the low concentration antifungal to its designated bank.  The 
medium concentration was prepared and administered along with the high concentration 
dilution.  Park and shut-down phases soon followed for the fluidics system while the 
payload maintained fluid and well plate temperature control and monitored growth for the 
remainder of the experiment. 
 The growth measurements were taken using a tri-color LED-detector combination 
similar to GeneSat-1; however the detector was spectroscopic and measured the biology 
in red, green, and blue absorption values.  The growth media was infused with Alamar 
Blue, a substance which oxidized from blue to pink as the yeast grew.  The amount of 
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pink in the well therefore indicated metabolic state of the biology much like fluorescence 
did with GeneSat-1’s E. coli.  Since the oxidized pink fluid was only composed of red 
and blue color components, the absorbed green value was a direct measure of well 
population.  Experiment test data is shown in Figure 2.7, displayed with the same 
telemetry analysis used by satellite operators after launch. 
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Figure 2.7 – PharmaSat Ground Optical Test Data – Tricolor LED readout for one 
well.  The entirety of the experiment can be backed out from this data.  The initial steep 
drop in values corresponds to well dosing.  A second small step (~10^5 counts) indicates 
a second dosing.  The curves indicate the transition from Alamar blue to an oxidized pink 
as the yeast grows and metabolizes the growth media.  Note the red component generally 
increasing while the blue slowly decreased.  The green component can be normalized to 
show cell population. 
 
 
 21
2.2.3 Payload Components 
 Although the spacecraft’s payload consisted of many electrical and mechanical 
components, only those directly responsible for the positive outcome of the experiment 
are modeled, and therefore these are the ones discussed in this section.  Many of these 
components were never intended for space flight let alone proven by heritage; therefore 
they are of particular interest in this anomaly management study. 
 The fluidics system was composed of 2 pumps, 13 valves, 5 waste bags, and 4 
media bags as well as over 1 meter of tubing in between these components.  These were 
all actuated by the fluidics PIC microprocessor depending on what phase the experiment 
was in.  Passive components included a check valve, bubble trap, hose connectors, and 
springs located inside the tubing to mitigate kinking.  A diagram of the fluidics network 
is given below in Figure 2.8. 
 
Figure 2.8 – PharmaSat Fluidics Network Diagram 
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 There were two different COTS pumps in the fluidics network.  It is worth noting 
that neither of these was originally intended for space flight.  A diaphragm pump 
(designated P-1 in Figure 2.8) is used for high flow rate pumping tasks such as 
recirculation and antifungal preparation, and a stepper pump (P-2) is used for highly 
precise tasks such as dispensing media and antifungal dilutions to the wells.  Figure 2.9 
shows the pumps used for the experiment. 
 
(a) Diaphragm Pump 
 
(b) Stepper Pump 
Figure 2.9 – PharmaSat Fluidics Pumps – (a) The diaphragm pump from KNF 
Neuberger pumps 50 mL/min (b) The stepper pump from The Lee Co. pumps 50 µL in 
500 steps thus having .1 µL precision    
 
 PharmaSat’s 13 microfluidic valves were also off-the-shelf products from The 
Lee Co. and have no previous space flight history.  These were all 3-way solenoid valves 
with common, normally open (NO), and normally closed (NC) ports.  No voltage over 
the leads kept the common and NO ports connected, while a 12V potential drove the 
solenoid over to connect the common and NC ports.  Two of these valves had sealed NO 
ports, thus operating essentially as on/off valves.  They were all rated to a 15 psi port 
differential while the pumps operated at 10-15 psi of instantaneous head pressure; 
therefore pumping fluid to a closed port would most likely result in a leak at the tubing 
connection or outright failure of the valve.  Figure 2.10 shows a CAD drawing of the 
solenoid valves.   
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Figure 2.10 – 3 Way Microfluidic Solenoid Valves 
 
 
  The heating elements used in the payload were strip heaters custom built from 
vendors Watlow and Minco.  Two card heaters were located on each side of the well 
plate attached on aluminum heat spreader plates using a pressure-sensitive adhesive.  The 
heaters conformed to the size of the well plate with holes located over each well to avoid 
interference with the optics.  A total of six temperature sensors were embedded in the 
heat spreader plates as part of the closed loop control system.  Similar strip heaters were 
wrapped around the fluidics reservoirs for thermal control with three temperature sensors 
providing feedback.  Figure 2.11 shows a CAD drawing of the aluminum heat spreader 
plates and card strip heaters. 
 
Figure 2.11 – Well Plate Heating System 
 
 The storage bags selected for the experiment were American Fluoroseal cell 
containment bags made of thermo-formed Fluorinated Ethylene Propylene Copolymer 
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(FEP) and were excellent at containing non-corrosive biological media.  Though used 
extensively on the ground in laboratory work, these too have no previous space flight 
history.  A total of 9 of these bags were used on the spacecraft for containing growth 
media, antifungal dilutions, and waste fluids.  The tubing connecting all media bags and 
fluidics components was a 1/16” ID Tygon hose commonly used in a variety of 
laboratory and industrial applications.  Figure 2.12 shows the entire payload assembly 
with the various components discussed in this section visible. 
 
(a) Top-Down Assembly View 
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(b) Close-Up View 
 Figure 2.12 – PharmaSat Payload Assembly – (a) Various components are visible 
here, including the solenoid valves (bottom), tubing, media bags, and payload circuit 
board.  (b)  Valves, tubing, and stepper pump shown in the package. 
 
 This thesis work focused on applying MBR to the engineering system described 
in this section.  The components discussed here were modeled and compiled into a 
system description used for evaluation of healthy and anomalous scenarios in the 
PharmaSat payload.  A detailed description of modeled components can be found in 
Chapter 3 and results of their implementation are presented in Chapter 4. 
 
2.2.4 Data Products 
 The primary data produced from the PharmaSat mission pertained to the 
biological growth in the payload.  Comparing the behavior of the yeast as it grew on orbit 
with that of the ground-based control experiment offered insight into the effects of 
microgravity on living organisms.  A wealth of supporting engineering data was also 
generated and downloaded from the satellite as a means of monitoring the health of the 
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satellite itself. Figure 2.13 shows an example of yeast growth after antifungal dosing in 
the measured constituent red, green, and blue colors from the flight experiment. 
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Figure 2.13 – PharmaSat Antifungal Concentrations – An increase of antifungal 
concentration did not permit the yeast cells to grow.  The lack of curves in the high 
concentration plot indicates that the Alamar Blue in the growth media was not 
metabolized by any growing cells and therefore did not become pink.  A slight curve at 
the end of the well with medium concentration indicated delayed and severely stunted 
growth.  Low concentrations yielded slightly inhibited growth compared to not using any 
antifungal at all.  An unfed well displays no changes throughout the experiment. 
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As illustrated in Figure 2.5, the biological well plate contained 4 banks of 12 
wells each that were injected with a different amount of the antifungal agent after the 
yeast cells had started to grow.  An operator looking at the growth data shown in Figure 
2.13 would need to be able to interpret the plots to understand whether or not the 
biological experiment is behaving as expected.  Such an understanding could speed the 
troubleshooting process significantly if a specific symptom was found and identified for 
the NASA team.  In the context of this research, determining whether or not a biological 
well was successfully dosed with any fluid (regardless of antifungal concentration) is of 
great importance.  A failure of one of the many components in the payload would 
eliminate the possibility of any growth, let alone the subtle differences in growth rates.  
The approach used for performing this determination autonomously is covered in Chapter 
3 with results shown in Chapter 4. 
 Significant amounts of engineering data were also used to assess the health of the 
spacecraft throughout the experiment.  An operator who is looking at the data for the first 
time would need to understand the constraints in which certain telemetry values would 
need to fall.  Sensor readings that fall out of the expected range would need to be quickly 
identified so potential work-around solutions could be implemented.   
A mission operator who is analyzing the data shown in Figure 2.14 would need to 
understand what they mean and whether or not the spacecraft’s payload is operating 
nominally.  For example, the payload card temperatures are shown to be oscillating 
between 5 and 15 °C in the beginning of the experiment.  This behavior is due to 
temperature fluctuations on orbit as the spacecraft cycles in and out of eclipse.  
Downward cooling trends are evident twice in the experiment; where temperatures 
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dropped to the minimum allowable at 5°C.  If the automatic temperature controller 
malfunctioned, the temperature would have continued dropping past the allowable 
minimum limit, possibly having negative consequences with the biology.  Likewise 
fluidic temperatures were maintained above 5°C to prevent freezing.  Once the 
experiment was underway, temperatures were held with a greater precision, requiring a 
tighter tolerance on acceptable bounds.   
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Figure 2.14 – PharmaSat Payload Health Data – Telemetry values are shown here 
from the PharmaSat flight experiment.   
 
 Payload humidity and pressure was also of particular concern for this experiment.  
Though some oscillation was visible due to thermal effects as the spacecraft orbited the 
Earth, values remained relatively consistent.  A significant depressurization or 
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uncharacteristic humidity would likely void the experiment and consequently the 
mission. 
 A full description of flight data and its use in verifying the anomaly management 
tool is presented in Chapter 4.  Depending on the data and which sensor it came from 
custom parameters were assigned to monitor their values as the mission progressed.  For 
example, it was crucially important to understand the rates at which growth values 
changed since this directly indicated the health of the yeast.  Therefore, rather than 
measure absolute values, the changes in slope of the plots were computed and reasoned 
on.  In the case of onboard temperatures, as long as their values fell within a certain 
bound, the payload was considered healthy.  The bounds changed as the experiment 
progressed, and the anomaly manager (much like an operator sitting on console) applied 
the relevant bounds to reason on payload health.  
 
2.3  Biological Testbed  
 
 To facilitate interactive testing of the MBR software with actual hardware, a 
biological test bed was created to emulate similar behaviors and features seen in 
GeneSat-1 and PharmaSat’s payloads.  Introducing anomalies into NASA flight hardware 
for testing the anomaly management software was clearly not an option; therefore, this 
test bed acted as a way to verify detection and diagnosis algorithms while introducing 
known anomalies.  While not intended for space flight, the goal was to prototype an 
analogous biological experiment using similar, if not the same components and 
techniques.  In order to make the prototype ‘interesting’ with respect to anomaly 
management, more components were used than necessary to accomplish the same 
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experiment.  The overall experimental complexity of this prototype was in between that 
of GeneSat-1 and PharmaSat, and there are elements which drew from both missions. 
 The biological experiment chosen was inspired from PharmaSat’s science.  The 
same S. cerevisiae yeast strain used for the flight was selected for this experiment.  It is 
easy to culture, completely harmless, and behaves analogously to PharmaSat’s biology.  
This makes it possible to conduct the same type of 96-hour experiment since this strain’s 
growth rates are essentially the same.  In the interests of scoping the project, the 
introduction of antifungal dilutions was left as future work.  
 The yeast’s growth was measured using a technique similar to that of GeneSat-1 
which used LED-photodiode combinations to measure physical light levels as a function 
of well turbidity and consequently biology population.  Infrared (IR) wavelengths were 
chosen to facilitate filtering of indoor laboratory lighting.  Covering the wells completely 
or working in darkness was less convenient and unnecessary for this experiment. 
 The well plate designed for the experiment used similar concepts as those seen in 
GeneSat-1 and PharmaSat, but focused on an inexpensive, easy to manufacture, and 
reusable design to facilitate testing.  Figure 2.15 shows a CAD illustration of the well 
plate design.   
 
Figure 2.15 – Biological Prototype Well Plate 
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Made of optically clear machined acrylic the well plate contained 6 wells at 400 
µL each.  The assembly was composed of three main components; the well plate itself 
and two covers.  Each well was sealed with a pair of o-rings and the entire assembly was 
tightened down with three bolts.  The input and output ports were tapped to allow a luer-
lock adaptor to thread into the well plate.  These adaptors allowed re-usable syringe 
filters to be quick-fitted onto the wells so as to isolate the biology sample only to the 
wells.  The filters chosen had a 1.2 µm pore size.  In contrast PharmaSat has 1 µm pore 
sizes allowing similar flow through the wells, but the embedded filter design of its well 
plate did not allow for re-usability.  Replacing the syringe filters and sterilizing the 
prototype’s plate in a diluted bleach bath was all that as needed for a quick turn-around to 
start a new experiment.   
The well assembly sat in between two aluminum heat spreader plates with a 
Minco strip heater attached via silicone glue.  The spreader plates not only housed the 
heater and its 4 associated temperature sensors but also the 6 IR LEDs and 6 photodiodes 
used for well turbidity measurement.  The photodiodes were run through a passive buffer 
circuit for signal conditioning and amplification.  Those voltage outputs as well as those 
of the temperature sensors were interfaced to a set of analog-digital converters which 
passed the data to a BASIC Stamp microcontroller responsible for temperature control 
and telemetry output.  Consequently, the well-plate heater was actuated with this 
controller.   A laptop running a MATLAB script was connected to the microcontroller 
and recorded the telemetry output for the duration of the experiment.  An image of the 
heater plates and sealed well biological wells is shown in Figure 2.16. 
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Figure 2.16 – Biological Wells and Heater Plates 
 
The fluidics network consisted of 1 pump, 4 solenoid valves, and 2 media bags all 
of which were interconnected with Tygon tubing.  To better emulate the behavior of 
PharmaSat’s experiment, the same pump, valves, and media bags were selected for the 
prototype with only a larger diameter of the same type of tubing used to facilitate the 
pumping of fluids.  The components were actuated via a second BASIC Stamp micro 
controller.  This Stamp was also responsible for sending state information to the 
telemetry microcontroller for the relaying of data to the laptop recording the information 
nearby.  In the interest of scoping and costs, only the KNF Neuberger diaphragm pump 
was used in the experiment, since the .1 µL precision of the Lee Co.’s stepper pump was 
unnecessary and its use would have doubled the cost of the prototype itself.  The layout 
of the prototype’s fluidics network is shown in Figure 2.17.  Full documentation 
including source code and electronic schematics can be found in Appendix A.2. 
 33
 
1
2
3
4
Filters
Well Plate
Connectors
Check Valves
Tubing
Diaphragm Pump
Media Bag
Waste Bag
Valves
 
Figure 2.17 – Prototype Fluidics Network Layout 
 
The experiment phases were designed to emulate those of PharmaSat, namely the 
use of a similar event driven state-machine for actuating components such as pumps and 
valves.  Analogous recirculation phases were used, with heated and non-heated sub 
phases.  The major difference was that the fluidics were not heated since they were 
maintained at room temperature in the laboratory therefore cold shocking the biology was 
not a concern. Upon starting the experiment (a physical switch was thrown) the growth 
media was recirculated as the well plate reached 80 °F (the same as PharmaSat’s set 
point).  The media was then administered to each pair of heated wells by actuating the 
appropriate valve for a short duration of time and driving the pump.  Over the course of 
the 96 hour experiment the banks were each dosed once more to provide additional 
nutrients and further increase the growth curve.  Telemetry readings were taken every 15 
minutes and relayed to the nearby computer.  Figure 2.18 shows an image of the 
complete biological prototype.   
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Figure 2.18 – The Biological Test Bed   
   
2.4 Chapter Summary 
 
Several engineering platforms were used in the course of this thesis research to 
validate approaches and concepts developed in the application of MBR to a biological 
microsatellite payload to increase mission operator efficiency.  The science and 
engineering data returned from the GeneSat-1 mission helped inspire the work done for 
this research project and served as an initial starting point in the decision support tool’s 
development.  Applying lessons learned from operations conducted in this biological in-
situ mission helped drive the requirements for future follow-on missions such as 
PharmaSat, the target platform for the research presented here.  To facilitate interactive 
testing of the MBR software with actual hardware, a biological test bed was created to 
emulate behaviors and features seen in GeneSat-1 and PharmaSat’s payloads.   
The increased complexity seen in the payloads of these spacecraft along with the 
use of non-flight rated components led to an increased probability of anomalous behavior 
while in orbit.  This also raised the difficulty in accurate real-time detection and diagnosis 
of anomalies for the operator, further justifying an investigation into streamlined 
characterization of such possible anomalies. 
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3. The Model - Based Reasoning System 
 
This chapter outlines the application of Model-Based Reasoning (MBR) 
techniques in the context of a biological nanosatellite application.  After summarizing the 
theory of MBR and relevant Anomaly Management (AM) extensions used in this 
research, the chapter describes the tool developed, modeling approach for fluidic 
components, and the graphical modeling environment used to accomplish this.  Lastly, 
the implementation of the overall system in PharmaSat’s ground segment is shown.    
 
3.1 Experiential Anomaly Management 
 
Given only a description of how a system is meant to perform and an observation 
of the system’s actual behavior, an inconsistency between the two can be characterized as 
an anomaly.  Historically the characterization of anomalies in engineering systems has 
been performed via human-based experiential reasoning techniques.  Humans directly 
involved with the system in question use their own expert knowledge combined with 
loose knowledge bases in the ways of plans, procedures, documents, etc. to intuitively 
create a list of possible faults to diagnose an anomalous behavior [16]. This method is 
effective at troubleshooting problems with the system when the people directly involved 
with its development are available to offer their extremely valuable insight.  The short-
term benefit with this method is a quick turn-around on anomaly management but it 
comes at an increased cost due to staffing the individuals involved.  Should these system 
experts leave the project, future anomaly management efforts would lack timelines, a 
systematic approach, and comprehensiveness in the diagnosis which invariably leads to 
increased cost and risk. 
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The MBR technique uses a formal knowledge-based and systematic reasoning 
framework derived from first principles so that a human operator need not be an expert to 
effectively detect and diagnose an anomaly [17].  Though there exists a higher upfront 
cost of developing the anomaly manager, the ability for non-experts to make accurate 
decisions given a symptom will decrease costs over time. 
 
3.2 MBR Anomaly Management 
 
 To address the shortcomings of traditional experiential anomaly management 
approaches, significant research has been performed in MBR in an effort to formalize and 
manage anomalies as they are encountered in a system.  Reasoning conjectures are 
computed from fundamental design knowledge which is represented in a system 
description.  The system description is used to define behaviors of each component in the 
system as well as a definition of the connectivity they have with each other.  With this 
information the performance of the system can be simulated thus allowing predicted 
outputs to be generated with the assumption that the system operates nominally.  
3.2.1 The Anomaly Management Process 
The heart of the AM process (Figure 3.1) lies with its ability to detect, diagnose, 
and resolve anomalous behaviors. 
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 Figure 3.1 – The Anomaly Management Process – Given a set of inputs and 
behavioral constraints the real system’s outputs are compared to those of a modeled 
representation.  The detection process determines whether or not there is a conflict 
between the expected and actual values in the outputs.  An inconsistency invokes the 
diagnosis algorithm which relaxes constraints to attempt to re-simulate the anomaly.  
Steps to resolve the anomaly can then be taken based on a list of conjectured diagnoses.  
It is important to note that this process can be automated or done manually, and 
depending on the system one may be a better solution than the other [1]. 
 
    
To provide further insight into MBR, the three key processes of anomaly management – 
detection, diagnosis, and resolution – are defined below. [1, 2, 13, 14, 15, 17] 
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Detection:  This process is a comparison between actual system data and the 
outputs of an evaluated system model.  The comparison takes place on the assumption 
that the outputs of the simulated system are the expected values.  All available data from 
both systems including configurations and consistency criteria are inputs for this 
algorithm.  The consistency criteria are output-specific and may either be checked by 
equality or the imposition of an acceptable behavioral bound.  If inconsistencies are 
found the outputs are flagged as symptomatic and passed to an algorithm responsible for 
diagnosing the problem. 
 Diagnosis:  The diagnosis of possible anomalies is found by considering 
operational constraints and attributes which are responsible for the behavior in question 
to be anomalous.  By relaxing or altering these constraints it is possible to place the 
modeled representation of the component back into congruence with the real system – 
thus appropriately pinpointing the source of an anomaly candidate.  Fundamentally 
diagnosis can be defined as a systematic process by which constraints and assumptions 
are relaxed within a re-evaluated system to match predicted and observed outputs.  
 Resolution:  Given a set of possible diagnoses, anomaly resolution ideally 
attempts to restore the real system to its original operating state.  If the nature of the 
anomaly renders normal operations impossible, the resolution process can strive to 
minimize the effects of the anomaly as a best-effort to achieve the primary goals of the 
mission. 
 This research project will assign the resolution process to the operator; thus 
placing the ultimate responsibility of taking appropriate action in the hands of a human in 
the event of an anomaly.  Figure 3.2 shows the anomaly management process illustrated 
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as a closed-loop system, where a desired goal or system state is achieved through either 
nominal operations or through successful corrective actions. 
 
 
Figure 3.2 – An Anomaly Management Overview – By representing the anomaly 
management process as a closed-loop control system, it can be shown that by 
appropriately detecting and diagnosing an inconsistent behavior the operator can restore 
expected outputs by manipulating input commands based on desired states, requirements 
and constraints [16]. 
 
3.2.2 Extended Anomaly Categorization  
 
 In the MBR framework employed by Santa Clara University’s Robotic Systems 
Laboratory there exists three types of anomalies which can be encountered.  Instead of 
focusing only on component fault detection, this technique incorporates the use of two 
additional conditions, classified as hazards and misconfigurations, to broaden the scope 
of possible anomalies [1].  A definition of fault, hazard, and misconfiguration states 
follows: 
Fault: A fault is a condition given to a behavior which does not match explicitly 
that which is described or modeled in the system description.  Fundamentally, the output 
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of the component is no longer a function of the input as is assumed under normal 
operation.   
Hazard:  A hazard is a behavioral condition that exists when operating in an 
unintended state or environment.  Typically there are constraints associated with the 
operation or use of any component which are given by sources such as a manufacturer or 
designer.  Though operating under violated constraints, the component may still be 
functioning properly and its behavior can still match that of normal operations.  For 
example, a micro-fluidic valve would be experiencing a hazard if it were operating at 1°C 
since the manufacturer has rated the guaranteed normal operation at a temperature range 
of 4°C - 49°C.  Even though the fluid pumped through the valve has not frozen, the valve 
may or may not function appropriately potentially jeopardizing the success of the 
satellite’s experiment. 
Misconfiguration:  This condition exists when the state of a component is not 
that which is assumed by the operator.  The output behavior is inconsistent based on a 
different configuration of component parameters and constraints.  This anomaly therefore 
not only accounts for operator error or misunderstanding, but in the case of an event 
driven system such as PharmaSat, a misconfiguration on the spacecraft could be due to a 
design flaw in a preprogrammed set of instructions which would only become apparent in 
rare or unexpected cases. 
 
 
3.3 Modeling Environment      
 
To fully automate and adapt the theories of Model-Based Reasoning, powerful 
software tools were needed to appropriately simulate system behaviors as well as to 
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generate and store data products efficiently.  The selection of an adaptable software 
system was necessary for the generation of a custom adaptation of MBR.  This software 
selection was also driven by previous in-house work so as to build and improve upon 
existing knowledge and techniques. [1, 2] 
 
3.3.1 The MATLAB/Simulink Environment 
The software chosen to conduct this research work was a computational package 
called MATLAB.  This is a high-performance programming language and development 
environment for technical computing.  The package is commonly used for the modeling, 
simulation, and analysis of a broad range of engineering systems. 
The modeling and processing relied on MATLAB’s embedded block interface of 
the Simulink graphical front-end.  Simulink offers users the same computational engine 
seen in MATLAB but with a graphical interface feature that makes modeling complex 
systems more intuitive.  Figure 3.3 shows a screenshot of MATLAB’s user interface. 
 
 
Figure 3.3 – The MATLAB Environment Interface 
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The drawback to having selected MATLAB is its computational inefficiency with 
regards to slow execution times.  The computational package offers a compiler which 
may serve as a means of reducing some processing times, however for the purposes of 
this research longer processing times were still perfectly acceptable.  The MATLAB 
development environment and graphical modeling tools more than justify the cut in 
performance. 
 
3.3.2 Embedded Block Application     
The use of embedded Level 2 M-file S-function blocks in the Simulink 
environment was the fundamental implementation tool in this research work.  While the 
block itself is presented visually to the user, the MATLAB scripting language drives the 
block.  Within the block a user can specify numbers of inputs and outputs and program 
the block to behave in a particular way.  Each modeled component had its own 
corresponding block whose behavior in code represented to some fidelity the behavior of 
the actual component.  Some components were modeled on a high level where only 
certain behaviors were necessary to be captured for the sake of anomaly management.  
Figure 3.4 illustrates a Simulink block and some of its corresponding scripted setup code. 
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function diaphragm_pump(block) 
% DIAPHRAGM PUMP - NF5-RP DCL 6V -> 50 mL/min   
% ASSSUMPTION - No residual volume in the pump 
setup(block); 
%-------------------- SETUP ----------------------
-- 
function setup(block) 
     
% SETUP PORTS 
block.NumInputPorts                        = 2; 
block.NumOutputPorts                       = 2;  
% DEFINE INPUT PORT PROPERTIES 
block.InputPort(1).Dimensions              = 10;      
block.InputPort(1).DatatypeID              = 0;        
block.InputPort(1).Complexity              = 
'Real'; 
block.InputPort(1).DirectFeedThrough       = 
false;  
block.InputPort(1).SamplingMode            = 0; 
  
  Figure 3.4 – A Level 2 M-File S-Function Block and Corresponding Code 
 
The Level-2 M-file S-function defines the properties and behaviors of the custom-
created blocks in the Simulink environment.  The function supports multiple inputs and 
outputs, multi-dimensional input and output signals, a variety of data types, multiple 
sample rates, user-defined workspace vectors, and tunable runtime parameters.  As will 
be discussed in subsequent sections, these features made the modeling of a biological 
incubation system possible with enough flexibility to allow the implementation of 
anomaly management techniques and algorithms. 
 
3.3.3 MySQL Database Implementation 
The MySQL database system is a multithreaded, multi-user application running as 
a server which allows for the storage and organization of data.  The open-source program 
is commonly used for web-applications, and libraries for accessing the MySQL databases 
are offered in all major programming languages. 
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This research project built on the existing data management system for the ground 
operation software used for the GeneSat-1 and PharmaSat missions.  As data are 
downloaded from the spacecraft, the telemetry is parsed and stored in a corresponding 
MySQL mission database.  Accessing stored data is possible through a specific 
Application Programming Interface (API) in MATLAB.  This API is used for the 
acquisition of the latest mission telemetry for use in the MBR simulation.  Figure 3.5 
illustrates the database user interface. 
 
Figure 3.5 – A MySQL PharmaSat Database Instance 
 
3.4 System Modeling Approach  
To appropriately model the system a generic approach needed to be implemented 
for standardizing the development and integration of individual components.  This 
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generic approach focused on creating reusable blocks whose modeled behavior was 
analogous to their real-world counterparts.  The models were constructed so that a non-
expert could efficiently use the system with next to no learning curve. 
This section discusses the generic modeling approach and how it was 
implemented in the design and creation of the biological payload model used for anomaly 
management.   
 
3.4.1 The NewMAAP Approach 
The NewMAAP project incorporated the use of MBR on the fluidic propulsion 
system based on the Cassini spacecraft as described in Chapter 1 [6]. The modeling of 
fluid flow in between actuated components of valves, thrusters, and storage containers is 
similar to that used in this research.  In the NewMAAP system, components had 
specifically defined modes of operation.  The transition between modes can be 
characterized as either a nominal transition corresponding to an expected behavior or a 
failure transition where the behavior of the component is no longer a function of the 
command given to it. For example, Figure 3.6 shows the modes and transitions of a valve 
and a valve driver.        
 
Figure 3.6 – NewMAAP Transition Systems for a Valve and Valve Driver 
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When in nominal operation mode, outflow = inflow which is constrained to equal 1 or 0 
for representing fuel flow or lack thereof, respectively.  The dynamics are modeled such 
that a commanded control input to the valve changes its state from Closed to Open and 
vice-versa.  Additional modes are Stuck Open and Stuck Closed representing failure 
modes which may or may not be resettable.   
While the modeled flow is similar, the notion of only explicitly defining two 
faults in the system deviates from the framework presented in this research and the AM 
technique in general.  Using the AM framework, when simulating an anomaly the outputs 
of the modeled valves are explicitly undefined; without any form of feedback defining an 
exact failure mode for the component is essentially speculation.  For example, if a valve 
ruptured and leaked, NewMAAP’s Stuck Open or Stuck Closed failure modes would be 
insufficient at explaining the anomaly.   
 
3.4.1 The Generic Structure 
 As discussed in section 3.2.2 the Level-2 M-file S-function was used for the 
modeling of all components.  The functional representation of a specific component 
stemmed from knowledge of the device’s operation.  Modeled component behavior was 
inherently stated as a function within the block’s script. 
The two most common types of data flow in between modeled components were 
representations of fluid flow and control signals.  The fluid flow was modeled as a vector 
containing volumetric flow rate information, concentration of media/antifungal being 
pumped, and environmental characteristics such as fluidic and payload temperatures.  
Control signals were modeled as required by the specific component.  The control input 
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for an actuated component was a logical 1 or 0 with the assumption that the 
corresponding voltage was sufficient to properly drive the component, since no sensor 
data could prove otherwise.  Additional control values were used based on specific 
component requirements and will be discussed in Section 3.5.  The diaphragm pump 
model shown in Figure 3.7 offers a good example of the use of all types of data inputs 
and subsequent outputs. 
 
Internal view of modeled component 
 
High level view 
Figure 3.7 – The Diaphragm Pump Block Subsystem – This image illustrates the 
various inputs and outputs common to a modeled component.  (a) – A vector representing 
fluid flow is depicted here.  (b) – The fluid output is modeled here and is a function of 
environmental and control inputs.  (c) – This is a control vector from the modeled 
microcontroller; a vector containing the logical 1 or 0 required for pumping as well as 
direction and duration of pumping information. (d) – This flag connects to a telemetry 
output in the simulation for the user.  (e)/ (f) – These ‘required volume’ vectors allow 
downstream components to have upstream effects; for example, pumping to biology from 
an upstream media bag.   
 
A required volume data path exists for the sake of modeling a continuous flow.  
Within Simulink inputs cannot act as outputs, and vice-versa.  To model a bidirectional 
behavior an input and output must be defined for each direction of data flow.  The 
required volume vectors were chosen as a solution to allow components to have upstream 
effects, since the modeled biological fluidics system was completely circular.  This 
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criterion was primarily created for pumps to ‘request’ a volume to be pumped from media 
bags located behind them in the fluid stream based on a commanded direction, flow rate, 
and duration of pumping.  Only pumps are able to actively request media to flow through 
the simulation.  A demonstration of the fluid flow progression is shown in Figure 3.8. 
 
Figure 3.8 – Modeled Fluid Flow Progression – Based on the pump’s control input a 
volume of fluid is requested from (a) to (b).  The fluid line passively sends this value from 
(c) to (d) where the growth medium reservoir ‘dispenses’ this volume in (e).  The fluidic 
line then passes the volume back to the pump in (f). Disconnected ports are associated 
with other modeled components using the same data protocol.    
 
In order to further manipulate functional blocks the use of MATLAB’s masking 
feature was used to edit parameters associated with the given component.  These 
parameters are an easy way for the user to edit environmental and behavioral values 
which affect the output of a component. Figure 3.9 shows the diaphragm pump’s tunable 
parameter window.             
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Figure 3.9 – Block Parameter Tuning Window – Parameters such as environmental 
limits are seen here and can be easily edited by the user.  Direct anomaly injection is also 
possible with the use of this interface. 
 
 
3.5 System Models 
This section describes three different system models created to help verify the 
design of the MBR system.  The need to develop a handful of models was driven by the 
necessity to test the detection and diagnosis algorithms efficiently as well as to verify 
component modeling.  Being able to use the same components in three different systems 
also demonstrated modularity so as to streamline the development of future biological 
payload models for upcoming heritage missions.  For an in-depth discussion of specific 
component modeling please refer to Appendix A.3. 
 
3.5.1 Simple Model 
  A simple model (Figure 3.10) was developed so as to verify functionality of the 
modeled components used in the biological experiment.  The model was run in two 
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different cases: as the ideal-case simulated system and as the ‘real’ system in which 
anomalies could be injected. 
 
 
 
Figure 3.10 – The Simple Model – Above: This model incorporated the use of one 
media bag, a single path for fluid, one pump, three valves, one well, and a heater.  The 
components were actuated using a single microcontroller model.  Both real and 
simulated cases were run using this model which allowed for direct comparisons.  
Below: a high level diagram shows the connections in the Simulink model above.    
 
Media Valve 
Valve 
Pump 
Valve Well 
Heater 
Controller 
Temp/  
Growth  
Sensors 
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Running both ideal and anomalous cases in parallel offered a way of developing 
techniques to detect and diagnose anomalies in an environment with reduced 
complexities.  This also enabled verification of each component’s expected operation.   
 The system implemented the use of a modified microcontroller model which was 
responsible for actuating a diaphragm pump, three valves (both A and B-type), and heater 
actuation to set the well plate card temperature.  There were a total of three phases 
modeled in this system; two recirculation phases (non-heated and heated fluidics) and a 
growth media delivery phase to the biology.  Additional components used for simulating 
the experiment were fluidic lines as well as growth media and waste bags. 
 For simplicity only one biological well was modeled.  The well model was 
adjusted to emulate the biological growth behavior seen in the GeneSat-1 mission 
telemetry.  Simple environmental factors including well temperature, growth media, 
relative humidity, and air pressure enabled growth when within pre-determined (nominal) 
bounds.   These values did not necessarily need to represent reality; rather they were 
placeholders for more complex models discussed later in this section.  The equations and 
logic describing the simulated behavior are shown below.   
If  Growth Media = 0 counts AND Temperature ≠ 0 °C AND  
Pressure ≠ 0 psi AND Relative Humidity ≠ 0 %  
Bio(t) = L0                                                                     [3.1] 
Else  If Growth Media > 0 counts AND Temperature ≠ 0 °C AND  
Pressure ≠ 0 psi AND Relative Humidity ≠ 0 %  
Bio(t) = L0 + G *log(max(1, t- t3)) 
Else  
Bio(t) = undefined 
 
Equation 3.1 – Simple Biological Model – L0 is the initial count level, G is the growth 
constant, t is experiment time, and t3 is the time at phase 3.  Specific environmental 
conditions and media feeding enabled growth in the well.  Outside of these expected 
conditions modeled growth was not permitted.  Any environmental anomalies would be 
expressed as a 0 in this simple model.      
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For the Simple Model L0 was set to 0 and was used as a placeholder for more 
complex models.  T3 was simply the elapsed simulation time up to Phase III where 
growth could begin. The log function is a simple logarithmic MATLAB operation whose 
output closely resembled that of GeneSat-1 data.  Lastly, the growth factor G was set to 
1.5 and was used as a placeholder for future biological models which would incorporate 
the use of stunted growth due to antifungal agents.  The violations of any imposed bounds 
would lead to an undefined growth behavior represented by MATLAB’s Inf value.  
Figure 3.11 shows nominal growth of simulated biology compared to GeneSat-1 data. 
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Figure 3.11 – Simple Model Biology – Nominal growth for the Simple Model (left) was 
modeled on GeneSat-1 optical density data (right) after a growth media signal was 
received by the well block and when environmental conditions such as pressure, 
humidity, and temperature were simply non-zero.  Placing more restrictive environmental 
bounds was to be done in subsequent models with increased complexity. 
 
The state of the well was monitored by two simulated sensors for optics and 
temperature.  Explicitly modeling sensors in the system allows perceived anomalous 
behavior to be also likened to faulty sensing.  The sensors themselves do not have any 
modeled error based on the assumption that the real components’ errors are too small to 
cause a measured anomaly.  Sensor outputs are written to text files for both ‘ideal’ and 
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‘real’ cases from where the detection script can pull and compare values.  Results from 
the use of this system are discussed in Chapter 4.  
 
3.5.2 Biological Prototype 
The biological prototype was created to generate real telemetry pertaining to the 
execution of an autonomous biological experiment similar to that of the PharmaSat 
mission.  The system model shown in Figure 3.12 shows the modeled biological 
prototype.  Appendix A.2 shows an enhanced version of this graphic. 
 
Figure 3.12 – Biological Prototype Model 
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Figure 3.13 – Biological Prototype Layout 
 
 
The same function blocks that were used in the Simple and PharmaSat models 
were also used to create this system description.  As with the real system (outlined in 
Figure 3.13 and described in Section 2.3), this graphical model incorporated the use of 
one diaphragm pump, four 3-way valves, one heater, four temperature sensors, six optical 
detectors for six biology wells, a growth media bag, waste bag, and fluidic lines 
connecting the appropriate components.  The two microcontrollers on the real system 
were modeled as one block for simplicity.  Simulated telemetry was compiled and written 
to a text file in the root folder.  A detailed outline of all experimental phases is shown in 
Appendix A.2. 
Repeated ‘ideal case’ testing in the actual prototype helped evaluate the biology’s 
behavior over time thus allowing for the creation of a reasonably accurate mathematical 
description of growth.  A simulated well allowed its analog/digital (A/D) count variable 
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to change according to a simple linear equation when a growth media signal was received 
and environmental conditions were in acceptable bounds.  In the event of multiple growth 
media dosings (as was the case with the prototype model) the A/D counter would 
increment a fixed amount for each time the media was administered.  As with the real 
system, more feeding increased overall growth registered by a higher aggregate change in 
A/D counts.  This was desirable because the resulting regression curve fit would contain 
a significantly higher slope, whose value was the metric used to determine a well’s 
health.  The role of regression curve fits and their slopes will be further discussed in 
Section 3.6.1.  The logic and equations used to generate the simulated biological growth 
are described below. 
If  Growth Media = 0 counts AND Temperature ≥ low_temp_threshold 
Bio(t) = L0         [3.2] 
Else If Growth Media > 0 counts AND Temperature ≥ low_temp_threshold 
Bio(t) = L0 – G * max(0, min(100, t- t3)) – G * max(0, min(100, t- t7)) 
Else  
Bio(t) = undefined 
 
 
Equation 3.2 – Biological Prototype Growth Model – L0 is the initial count level, G is 
the growth constant, t is experiment time, t3 and t7 are the times at phases 3 and 7, 
respectively.  Given an adequate environment and a growth media signal the well’s 
growth equations were enabled. Pressure and humidity were not included due to the 
experiment being performed in a laboratory.   
 
For this model the variable L0 was set to 10 A/D counts based on initial readings 
from the real system.  Once simulated growth media was delivered to the well and the 
temperature was above the low_temp_threshold of 20 °C the A/D counts decreased with a 
linear slope of -0.3 counts/sim-step which was defined by the growth constant G.  The 
aggregate A/D value was re-evaluated each simulation step and capped at 100 steps.  This 
process was performed twice given the two media dosings resulting in a greater overall 
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drop in A/D counts signifying more growth.  As with the other models developed in this 
research project, it is important to note that modeling a general behavior would suffice.  
For example, the time duration of the real and simulated systems did not have to match so 
long as the general behavior was analogous.  In this case the curve fit needed to have 
similar properties for the detection algorithm to consider the two models analogous.  A 
decreasing exponential curve from a single dosing would have likely provided a better 
fidelity model, though either approach was sufficient.  Figure 3.14 compares the 
telemetry generated from the real system compared to that of the simulation. 
 
Figure 3.14 – Real vs. Simulated Growth – As more yeast grew in the well, the amount 
of transmitted light decreased.  The plot on the left shows this behavior from the real 
system while the simulated behavior is shown on the right. It is worth noting that A/D 
counts are decreasing due to the sensing employed in this experiment.  Other systems 
described in this chapter show increasing counts. 
 
 The experiment was modeled on a phase-by-phase basis rather than a continuous 
time-based approach.  This meant that while each phase had an expected behavior, the 
simulated duration of a given phase did not necessarily correlate to that of the actual 
system.  There was no need to simulate phases that lasted for hours as long as the 
behavior of that phase was modeled appropriately.  It was empirically determined that 70 
simulation steps were adequate to model the behavior of each phase.  A block which 
processes an input and returns a valid output takes one step.  This makes the total number 
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of steps in a phase a function of the number of components in the system.  An additional 
margin was imposed so as to aid the user by allowing time between phases for visual 
reference in the graphical interface.  Even with this margin included, the total time to a 
complete simulation for the 70 hour prototype experiment was approximately 27 seconds.   
Each simulation step generated its own string of telemetry which was written to a 
text file.  The format of this output string is shown below: 
output = [phase, clock, B1, B2, B3, B4, P1_dir, duration_on, 
card_set_point, card_heat, card_heat_stability, optical_condition, 
experiment_armed_state, temp_1, temp_2, temp_3, temp_4, temp_avg, 
optics_1, upper_bound_1, lower_bound_1, optics_2, upper_bound_2, 
lower_bound_2, optics_3, upper_bound_3, lower_bound_3, optics_4, 
upper_bound_4, lower_bound_4, optics_5, upper_bound_5, lower_bound_5, 
optics_6, upper_bound_6, lower_bound_6]; 
 
Figure 3.15 – Simulation Output String  
 
 
The data string provided information about the current state of the system 
including phases, pump and valve states, temperatures, and optical readings.  
Additionally, optical bounding conditions were physically modeled.  These provided two 
‘worst case’ scenarios for each phase in between which the actual biological growth 
measurement was permitted to be without being flagged as anomalous.  Due to the nature 
of the prototype system, these bounding conditions were relatively loose given the 
inherent noise in the sensing and were not immediately used in the detection process. 
Results from the use of this system to detect and diagnose anomalies in the real test bed 
are presented in Chapter 4. 
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3.5.3 PharmaSat Model 
The high fidelity model used for PharmaSat implementation is presented here 
along with techniques and pitfalls of modeling such a complex system.  A total of 175 
components were modeled including fluidic components, biological samples, and sensors 
for telemetry generation.  Figure 3.16 shows the entire payload model as developed in 
Simulink.  For a higher detail figure and fluidic diagram please refer to Appendix A.1.   
 
Figure 3.16 – PharmaSat Payload Model  
 
 
Model blocks used in this system were identical to those discussed in the previous 
two sections.  The addition of a stepper pump model, check valve, antifungal bag, 
dilution bag, additional waste reservoirs, fluidics heater, 3-way valves connected in 
reverse, tri-color LEDS for biological colorimetry, and corresponding optical sensors 
were the biggest changes to the model besides the combined quantity of all components. 
All 12 phases of the experiment were modeled here including 51 sub phases 
resulting in 111 unique steps.  These phases are outlined in Appendix A.T.1.  The file 
expected_values.m physically stored each step which the simulation used as a reference.  
A separate file eased editing entries through the development of not only the model, but 
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the satellite as well.  For example, the PharmaSat payload underwent a calibration 
procedure in which the exact number of steps the pump is commanded to run at changes 
between flight units.  This is due to uneven fluidic line lengths and other small hold-up 
volumes in the pumps and valves which may affect antifungal concentrations.  After 
testing was completed these calibrated pump values were easily substituted into the file.  
 The microcontroller model block executes a function call at the start of the 
simulation which loads all entries from expected_values.m into memory, then 
sequentially executes each step throughout the experiment.  Upon actuating the 
appropriate pumps, valves, and heaters the controller also outputs its current state to a 
telemetry logging block.  Recording each experiment state is essential for checking the 
configuration of the experiment on the spacecraft.  Though states were preprogrammed 
on the spacecraft (much like in the simulation), occasionally in testing unanticipated 
configurations would produce anomalies; checking for these in flight was imperative. 
 Payload environmental elements are modeled as well.  Temperatures are actively 
controlled through the well plate and fluidics heaters.  An assumption in the modeled 
system is that the set point of a heater is in fact the temperature of the component(s) it is 
heating.  The modeled temperature sensors consequently output this set point temperature 
which is used for fault and hazard checking. 
 The relative humidity and air pressure are both passive in the payload and 
therefore constant in the simulation.  Bounds are imposed on the real system’s telemetry 
when compared to these ideal values.  The simulation’s ideal pressure and humidity 
values were updated upon the final loading of the payload before launch when the 
canister was sealed.   
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Lastly, the payload’s modeled biology offered unique ‘ideal case’ behaviors 
which provided predictions as to how the real biology would grow.  These models were 
in essence no more complex than those used in the prototype and simple models 
discussed above; however the mathematical description of their dosing and growth was 
chosen to exhibit the behaviors which were relevant to determining the state of health of 
the real experiment.  These characteristics included a change in light intensity after 
growth media dosing D, a growth constant G which would attenuate or accelerate the 
growth of the simulated biology based on how much antifungal was predicted to be 
present, and a lack of any of these behaviors if the modeled environment or fluidic 
system was in an anomalous state.  As with the real unit, each simulated well produced 
data for red, green, and blue channels.  In the case of the PharmaSat experiment, it was 
perfectly acceptable to leave the equations identical for all three color channels in a given 
well because they all exhibited similar behaviors in the real system.  The logical 
constraints and subsequent equations for the model are summarized below: 
If  Growth Media = 0 counts AND Temperature ≥ 5 °C AND  
Pressure = 14.25 ± 1.25 psi AND Relative humidity = 65 ± 25% 
Bio(t) = L0          [3.3] 
Else If Growth Media > 0 counts AND Temperature = 27 ± 2 °C AND  
Pressure = 14.25 ± 1.25 psi AND Relative Humidity = 65 ± 25% 
Bio(t) = L0 – D + G * log(max(1, t-t3)) 
Else 
Bio(t) = undefined 
 
 
Equation 3.3 – PharmaSat Well Growth Model – L0 is the initial count level, D is the 
drop in counts after media dosing, G is the growth constant, t is experiment time, and t3 is 
the experiment time elapsed at phase 3.  Though the model includes more stringent 
environmental considerations, its overall structure is similar to that of more basic models 
described earlier in this section. 
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Figure 3.17 shows a typical output from all three simulated color channels.  The variation 
in growth performance is dictated by the growth constant G from Equation 3.3. 
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Figure 3.17 – Simulated Optical Measurements – A typical output is shown for a 
simulated color channel showing the biological growth model after the entire experiment 
duration.  Note the change in growth performance given different growth constant values. 
 
The biological models described in this section provided a defined growth behavior 
only when all environmental parameters were known to be within certain bounds.  
Outside of these pre-determined bounds the behavior of the biology was not guaranteed 
to be predictable; therefore the simulation made no attempt to predict such outcomes.  
The real biology could perhaps grow in unknown conditions however there existed no 
data for these permutations.  Its growth would be described as “anomalous,” meaning 
having occurred outside of a pre-defined envelope of constraints. This is significant with 
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regards to the experiment’s outcome since its premise involved the removal of all 
variability except microgravity between ground and flight units.  More insight on the 
characterization of biological growth behaviors is offered next. 
 
 
3.6    Applied Anomaly Management 
This section revisits the anomaly management algorithms discussed in Section 3.1 
and presents how they were implemented in MATLAB and applied to the models 
illustrated in Section 3.5.  The functions accessed data produced by the real and simulated 
systems and were capable of manipulating the models in the event of a detected anomaly. 
The experiment carried out on the PharmaSat mission was designed to be 
autonomous with limited human intervention.  The experimental data products created by 
the spacecraft were downloaded by mission operators and could potentially be freshly 
recorded or weeks old.  Additionally the nature of these downlinks would be such that no 
immediate resolving action would be taken since the operators were engaged in 
downloading as much data as possible in a very short window (approximately 10 minutes 
per contact).  Consequently, this decision support tool did not need to act exactly in real 
time and near-real time performance with short processing times was acceptable.  
Existing data that had been downloaded from the spacecraft, including new data just after 
the contact, could be processed and anomalies could be detected and diagnosed.  Once 
this type of decision support tool was implemented in the ground segment for a 
spacecraft, it could aid mission operators in planning the next set of commands as the 
spacecraft orbited back around for another contact. 
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3.6.1 Detection Algorithm 
The detection algorithm was implemented in a MATLAB function and used a 
system of comparisons to check for consistency between real and simulated telemetry 
with the assumption that a deviation indicated an anomalous symptom.  The system 
model is run initially with a nominal configuration to generate the real system’s predicted 
values.  
Upon generation of these predicted values, the system is checked for consistency 
using the detection.m function.  Specifically, the following checks are made: 
• Any values that are part of the spacecraft’s event-driven state machine are 
checked with predicted values.  For example, such consistency checks are 
performed for telemetry regarding pump states, valve states, and various 
conditions such as optical, thermal, and experimental arming that need to be met 
before the next phase of the experiment is allowed to proceed.  Inconsistencies 
with these comparisons are found by inspection and reported to the user as a 
possible misconfiguration.   
•  Telemetry values that are found to be inconsistent with pre-determined constraint 
bounds (including parameters involving environmental conditions) are found by 
inspection and reported to the user as a possible hazard.  
• Lastly, growth behaviors are compared for real and simulated systems.  The 
biological growth is the best sensor for the state-of-health of the payload.  Should 
there be a measured discrepancy between the two, it is indicative of a wide variety 
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of possibilities which are not directly observable.  The constraint relaxation 
technique is therefore invoked to diagnose the anomaly.  
`  
 
Figure 3.18 – Detection Algorithm – Once telemetry is downloaded from the spacecraft 
predicted values are generated and a series of checks are performed [1].  If there are 
inconsistencies symptoms are appended to a list thus invoking the diagnosis algorithm. 
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to be directly oberservable and are reported as such.  The symptoms found by the third 
check are not caused by immediately observable behaviors and require the constraint 
relaxation technique discussed in the following section for making diagnosis conjectures. 
A portion of the detection algorithm involved the behavioral characterization of 
the onboard biology.  Though biological growth will never be completely repeatable, 
significant resources had been expended by the PharmaSat team to minimize variations 
between experiments.  This offered a well-characterized behavior that could be abstracted 
and interpreted autonomously on a high level.  As the premise of the experiment would 
suggest, with all variables kept constant, the variation between ground and flight 
experimental growth may be attributed to microgravity.  However, with external 
variables not kept constant, biological growth can vary significantly from expected 
behavior.  Given that this research focused on payload state-of-health, variables of 
interest were hardware health and environmental attributes (temperature, pressure, and 
humidity).  Problems with biocompatibility or effects from microgravity, among many 
other variables, were not considered. 
To better interpret the behavior of the biology in the PharmaSat experiment, three 
measurements were performed on both simulated and real data sets for each well’s red, 
green, or blue color channel.  The results of each of those measurements, when 
considered together, indicated the health of the biological well.  By setting definitive 
thresholds to these measurements, a quantitative characterization could be derived from 
an otherwise subjective assessment that a satellite operator would have to make. 
The thresholds were determined empirically by analyzing available data from 
both ground experiments and in flight.  After calculating the appropriate metrics for all 
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available wells, defining minimum criteria for growth required expert opinion.  Wells that 
exhibited minimal growth behaviors were therefore used as the benchmark.  After a small 
safety factor was incorporated to lower the minimum criteria slightly, a performance 
envelope was effectively created.  Those wells whose measured characteristics fell 
outside of this envelope did not grow any biology.  Table 3.1 shows selected thresholds 
for both real and simulated cases.  A discussion follows which details each threshold 
criterion. 
 
Detection Threshold 
Criteria 
Dose Drop 
(counts) 
Maximum Slope 
(counts/sec) 
Absolute Change 
(counts) 
Real Wells 9000 ± 0.4 1000 
Simulated Wells 2 ± 10-5 50 
 
Table 3.1 – Experimental Detection Thresholds – These thresholds were determined 
empirically by evaluating available data from ground, flight, and simulated experiments.  
Though initial evaluations required the opinion of an expert, once implemented, any user 
could make assertions regarding growth assuming the envelope was defined accurately. 
 
 
The first measurement involves finding whether or not a well has been dosed with 
growth media early in the experiment.  This dosing has a distinct behavior in that the 
optical intensity readings of all three color channels drop a significant amount in a very 
short period of time.  This is an indication of growth media infused with Alamar Blue 
being pumped into a well which was optically clear and full of de-ionized water.  The 
change in light transmittance is therefore an indication of healthy upstream fluidic 
components which delivered growth media to the intended target. This case is shown in 
Figure 3.19. 
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Figure 3.19 – Dosed Well Example – The drop in measured light intensity produces a 
quantifiable behavior in both real (left) and simulated data.  Dosing criteria is evaluated 
individually on each color channel in the two systems.  The threshold for the real data is 
set to 9000 counts/ 2 hours.  The simulated threshold is 1000 counts observed 
instantaneously.  
 
After growth media dosing (or lack thereof) is identified, the next measurement 
involves the interpretation of biological growth.  As is the case with many biological 
specimens, a yeast population’s rate of growth is directly proportional to its overall 
health.  Therefore the method chosen for abstracting and interpreting the biological 
growth is based on the derivatives of statistical regression curves.  By fitting a 
polynomial trend line a continuous mathematical approximation can be made on discrete 
experimental data points.  In regards to this research, the best use of the trend line is not 
in absolute values but in changes in slope.  A variation in slope above a defined threshold 
indicates a rapid change in growth behaviors or experiment state.  This assessment may 
or may not be desirable and depends on where it was observed.  For example, a well in a 
freshly dosed bank with no antifungal would presumably have a measured growth event 
with a rapidly changing slope.  A reference well which never saw any growth media 
would be flagged as symptomatic based on there being detected growth where none was 
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expected.  Figure 3.20 shows an example where growth is detected after successful 
dosing of a well, for both real and simulated cases. 
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(a) – Real Data/ Growth Event  (b) – Simulated Data/ Growth Event 
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(c) – Measured Slopes, Real Data  (d) – Measured Slopes, Simulated Data 
Figure 3.20 – Detected Growth – Cases (a) and (b) show a rapidly changing slope after 
dosing which indicates growth.  Plots (c) and (d) offer a quantitative measurement of the 
quality of growth from these wells.  A well whose slope is found to be over the set 
threshold (±0.5 counts/sec for both real and simulated data) is therefore considered to be 
actively growing. 
 
The final measurement involves finding the absolute change in intensity values 
after a dosing event has been detected.  This is an especially important measurement for 
wells which offer highly stunted growth or no growth at all.  In these cases the change of 
slope necessary to evaluate growth quality is small enough to either fall under the 
threshold or not be discernable from noise inherent in the curve fitting process.  
Measuring the absolute change in light intensity for each well’s color channel (simulated 
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or real) offers another way of determining whether or not a change has occurred over 
time.  Specifically, this measurement is made by subtracting the minimum intensity found 
from the maximum so as to negate any ripple from either the biology or the sensor.  
Figure 3.21 illustrates the nature of this measurement for both real and simulated 
telemetry. 
 
Figure 3.21 – Absolute Measured Intensity Change – For each color channel in a 
given well, the minimum measured value is subtracted from the maximum and compared 
to a predetermined threshold.  The maxima and minima for both real and simulated data 
are illustrated by a magenta line.  The threshold was set for 5000 counts in the real data 
and 400 counts for simulated data.   
 
Based on these three measurements, a wide variety of cases could be evaluated for 
both nominal and off-nominal scenarios relating to PharmaSat’s biology.  An unfed well 
with no growth would exhibit a flat lined behavior, resulting in no detected changes to the 
light intensities throughout the experiment.  Figure 3.22 illustrates this type of behavior. 
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(b) – Simulated Data 
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(c) – Real Data Slopes 
 
Figure 3.22 – Modeled vs. Real Undosed Well – Without a dosing of growth media 
there is no significant drop in light intensity.  Even a temperature-induced fluctuation 
seen in (a)’s red channel is not sufficient to go above the threshold.  However, this 
fluctuation creates noise in the slope calculation (c), even though it is generally under the 
threshold.  The simulated data in (b) by inspection has a slope equal to 0.     
 
In the event of dosing but no growth, such as what is seen in the high 
concentration wells, one of the three measurements is found to be true.  Slope 
measurements and absolute values of growth remain near zero after the dosing threshold 
is exceeded.  Figure 3.23 illustrates this case.  
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(b) – Simulated Data 
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(c) – Real Data Slopes 
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(d) – Simulated Data Slopes 
Figure 3.23 – Modeled vs. Real Dosed Well With No Growth – The fluidics network 
successfully delivered growth media to the biological well but no growth was measured 
in any of the color channels.  This leads to near-zero slopes and no significant change in 
light intensity after initial dosing.      
 
When a medium concentration of antifungal is applied to the biology, some 
growth is typically visible; however it appears to be very limited.  In this case it is 
important to measure the dosing and any net change over time.  Attempting to measure 
the slope alone will likely be unsuccessful because of how slow the growth progresses in 
the experiment.  Slow growth and small slopes land under the detection threshold and are 
therefore not considered in this case.  Figure 3.24 describes this scenario. 
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(b) – Simulated Data 
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(c) – Real Data Slopes 
 
(d) – Simulated Data Slopes 
Figure 3.24 – Modeled vs. Real Dosed Well With Some Growth – Stunted growth is 
visible due to the higher dose of antifungal.  In this case the slope becomes difficult to 
measure and is ignored.  It is more accurate to detect dosing outright and measure a 
cumulative change in light intensity over the experiment duration. 
 
Low concentrations of antifungal lead to only slightly stunted growth which will 
nominally exceed all three thresholds (dose, net change, and slope) for both simulated 
and real data.  Figure 3.25 shows this case. 
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(b) – Simulated Data 
3.75 3.8 3.85 3.9 3.95 4 4.05
x 106
-1.5
-1
-0.5
0
0.5
Timestamp(sec)
Ta
o
s 
In
te
ns
ity
 
(c) – Real Data Slopes 
 
(d) – Simulated Data Slopes 
Figure 3.25 – Modeled vs. Real Dosed Well With Acceptable Growth – This case 
offers a look at successful dosing for all three channels, rapid changes in slope, and 
overall growth after dosing.  Growth is slightly stunted (as expected) due to the low 
concentration of antifungal in this bank.   
 
Lastly, the 12 wells in the control bank never saw antifungal and thus enjoyed 
unrestricted growth.  While the dosing behavior remained the same as all other wells, 
measured slopes and net changes in intensity were both the highest in the experiment.  
All three thresholds for each color channel were exceeded thus indicating a completely 
healthy well.  Figure 3.26 provides a typical example. 
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(b) – Simulated Data 
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(c) – Real Data Slopes 
 
(d) – Simulated Data Slopes 
 
Figure 3.26 – Modeled vs. Real Dosed Well With Unrestricted Growth – This case 
shows dosing, crisp slopes, and ample changes in intensity indicating on all levels that 
both the real and simulated wells are completely healthy. 
 
The lack of substantial sensing in the PharmaSat payload and the general fragility of 
biological samples made the measured growth behaviors the best ‘sensor’ for the 
spacecraft’s state of health.  It was therefore important to classify these behaviors in a 
manner which would quantitatively indicate the state of the experiment to a fairly high 
degree of precision with a quick turn-around.   
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3.6.2 Diagnosis Algorithm  
Upon a compilation of symptoms from the detection script, the diagnosis 
algorithm outputs components which have possibly caused the erroneous behavior.  All 
symptoms are initially passed to the operator before the diagnosis algorithm is invoked.   
Anomalies must lie upstream from where the symptom was found.  Therefore for 
each symptom a list of upstream constraints is generated, including behaviors, operating 
conditions, and configuration statements. Commonly there exist multiple symptoms for 
only one anomaly which necessitates multiple upstream component lists.  The 
intersection of these lists is the set of upstream components that are common to each 
symptom and therefore represent the candidate list. 
  Having compiled the final component list the diagnosis algorithm sequentially 
forces each model block into an undefined state by manipulating the fault_flag of the 
block.  For each candidate, the experiment is simulated with the component’s operational 
constraints relaxed.  With the anomaly simulated, the resulting telemetry is once again 
compared to the observed values of the real system using the same detection algorithm.  
If no symptoms are found the anomaly was successfully simulated and the component 
under evaluation is added to a candidate list.  The component is then forced back into a 
nominal state and the next component on the upstream is evaluated.  A flow chart of the 
diagnosis algorithm is illustrated in Figure 3.27.  
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Figure 3.27 – Diagnosis Algorithm – Given symptoms, constraints are relaxed, the 
system is re-evaluated, and candidate anomalous components are displayed [1]. 
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3.7   Chapter Summary 
This chapter illustrated the fundamental theory behind Model-Based Reasoning 
and showed how this theory was applied to a real-world engineering system.  The use of 
a graphical modeling environment allowed the creation of system descriptions unique to 
biological incubation payloads for anomaly management.  More specifically it was 
necessary to capture constraints and behaviors unique to the PharmaSat payload in the 
system model thus necessitating experiments of varying complexity to verify proper 
operation of this decision support tool.  The same model components were created and 
reused in three experiments; all of which incorporated identical algorithms for detection 
and diagnosis conjectures in the event of an anomaly.  This also demonstrated modularity 
between systems and adaptability not only for the PharmaSat experiment, but future 
heritage missions involving biological payloads.    
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4.  Experimental Results 
 
 The application of Model-Based Reasoning techniques to a biological system was 
validated through a series of experiments before testing with the payload of the 
PharmaSat spacecraft after its launch.  This chapter discusses such testing scenarios and 
presents results pertaining to the injection of anomalies as well as unplanned component 
failures in preparation for PharmaSat mission operations.  Lastly, results from testing 
with the spacecraft in orbit are presented. These results validate the approach used and 
demonstrate the decision support tool’s speed and accuracy for use in on-orbit mission 
operations. 
 
4.1 Observability 
 
A telemetry snapshot of the spacecraft’s payload state is logged every 8 minutes.  
This snapshot offers a glimpse into the health and status of the spacecraft over the 
mission lifetime.  While the data’s resolution is perfectly adequate for deducing 
anomalies over time, it is not logged quickly enough to guarantee feedback on critical 
events.  These events are namely the repeated actuation of pumps and valves in the 
fluidics network; an essential part of the experiment execution.  For example, feedback of 
these events could be measured by a brief spike in current draw upon expected actuation.  
A more novel solution proposed early in the design involved listening for actuation by 
use of a small microphone.  Not having immediate critical event feedback is still 
acceptable in a high-risk low-cost mission.  Therefore, the best critical event sensing that 
the anomaly manager could take advantage of was the biological growth itself.   
 79
This system also included numerous components strung together serially.  
Without a means of probing for sensing in between concatenated components, often 
times a single point of failure can only produce an ‘everything upstream’ candidate list 
since there is no information to suggest otherwise.   
Acknowledging these limitations, the anomaly manager is still able to quickly 
detect an anomalous condition and within minutes offer a possibility as to what may have 
gone wrong with the spacecraft’s payload.  This capability is still a great asset to any 
mission operations team. Without it, operators would need to possess expert knowledge 
of a complex system to meticulously analyze telemetry and make conjectures while 
adequately informing mission management of the situation. 
 
4.2 The Simple Model 
 
To first validate the algorithms used in this system a simple model was created 
using existing component blocks.  This model acted as a test bed with reduced 
complexities and offered a means to troubleshoot while the tool was in the development 
phase.  Two identical models were executed: one acting as the observed (‘real’) system 
and the other acting as the ideal case simulation.  Anomalies were injected into the 
observed system and were later diagnosed using the simulated case. 
 
4.2.1 Modeled Valve Failure 
Though the valves used on the PharmaSat system were flight qualified, their small 
size, relatively fragile nature, and immediate importance to the successful execution of 
the experiment made them a good candidate for checking fault detection and diagnosis 
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algorithms.  Since there is no direct feedback as to whether or not a valve has operated 
nominally on the spacecraft, a candidate fault condition can only be inferred by 
simulating a failure and analyzing the results. 
In the model acting as the real system, Valve B-1 was forced closed to simulate an 
outright malfunction.  The model then ran through the entire experiment generating 
telemetry that would be checked by the detection algorithm.  Figure 4.1 shows a plot of 
generated telemetry of the two simulations each having executed once.   
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Figure 4.1 – Predicted vs. Observed Model Telemetry - All telemetry is included in 
one plot.  If the system was healthy note that all values would completely overlap.  
However, a flat line is observed with the ‘real’ yeast, indicating no growth. 
 
Growth metrics were compared for both the simulation and real models and a symptom 
was found.  The real yeast was found to be out of expected bounds with no change in 
regression curve fit slope.  This generated a symptom which invoked the diagnosis 
algorithm thus evaluating all logical upstream components.  The symptom originated 
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from the first point of sensing, in this case the optical sensor which measures growth.  A 
list of diagnosis conjectures is shown after the algorithm was invoked. 
 
Figure 4.2 – Simple Model Diagnosis Output – After detecting a symptom, it is 
observed that all fluidic components upstream from the growth media bag (GM) are 
anomaly candidates due to the serial component connections.  Nevertheless, 
environmental components are not considered, and no hazards or misconfigurations 
were found; a good initial test of the algorithms.  These candidates (including the faulted 
Valve B-1) were identified in less than 3 minutes.  This marked an excellent first step 
which validated the desired approach for this research project using a simple model.    
 
The generation of a handful of candidate components in the fluidic network in of itself is 
not necessarily interesting since this system’s observability is limited.  However for the 
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testing of model execution, configuration criteria, and constraint descriptions, the result 
was a positive step forward in diagnosing anomalies based on the behavior of a biological 
sample.  Figure 4.3 shows part of the simulation running as each component’s constraints 
are individually relaxed. 
   
 
Figure 4.3 – Valve B-1 Induced Fault State – Valve B1 was forced to an ‘off’ position 
to simulate a fault.  This caused the fluid signal to bypass the well and circulate back 
through the modeled fluidic system.  Evidence of the well’s lack of growth is indicated by 
the two 0 values, one for fluid signal and one for corresponding growth.   
 
   
4.2.2 Modeled Heater Failure  
The payload heater is required to incubate the biology samples and maintain them 
at a constant temperature to maintain experimental accuracy.  As seen after the primary 
experiment was completed on the GeneSat-1 mission [21], a failed well plate heater will 
cause large temperature swings on the payload card as the spacecraft transitions from 
sunlight to eclipse and back.  For the purposes of this model, ambient temperatures are 
set as an adjustable constant and typically lower than the set point of the heater controller.  
The thermal model is basic; for example, losses due to heat transfer are not considered. 
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When a simulated heater failure occurred, the temperature of the well plate 
dropped significantly thus retarding the growth of the biology.  Some growth is still 
visible (Figure 4.4) since the sample was successfully dosed with growth media.        
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Figure 4.4 – Modeled Well Plate Heater Failure – Real biology growth (black) is 
visibly slowed compared to the predicted case (yellow).  The anomaly manager detected 
growth that was out of acceptable bounds, but after curve fitting and applying a slope 
threshold it was determined that some growth had occurred, likening a temperature 
related anomaly over that of the fluidics network. 
 
Since some growth was detected and the temperature was inconsistent, the symptom 
originated at the temperature sensor as opposed to the optical sensor.  The upstream list 
compiled therefore included the temperature sensor, biology sample, and heater.  Figure 
4.5 shows the output given to the user once the diagnosis algorithm had relaxed 
constraints in each case.      
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Figure 4.5 – Simple Model Diagnosis Output – The anomaly was detected at the 
temperature sensor and diagnosed to be the heater in less than 1 minute. 
 
 Though the temperature sensor is where the symptom was originally detected, the 
diagnosis algorithm only returned the heater as an anomalous candidate.  This logically 
makes sense; had only the temperature sensor failed the biology’s growth would have 
remained unaffected.  Had the well itself failed no growth would have been seen at all.  
Therefore the only remaining candidate in the upstream list had to affect both 
temperature and growth and by faulting the heater the correct symptomatic behavior was 
exhibited.  As a sanity check, the failed temperature sensor case in shown in Figure 4.6. 
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Figure 4.6 – Simple Model Failed Temperature Sensor Case 
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4.3 Biological Prototype 
Once the approach and algorithms were verified on the Simple Model, the added 
complexity of the biological prototype was introduced for hardware-in-the-loop 
verification.  The experiment was designed to exhibit as many similar characteristics to 
PharmaSat as possible so that the anomaly management process could be refined before 
the satellite’s launch.  The fluidic components and yeast strains used were identical to 
those of the flight unit.  Growth media, heaters, sensors, and supporting circuitry were 
closely analogous.  The test bed is discussed in detail in section 2.3 and a close up photo 
is shown in Figure 4.7.  The experiment generated the same telemetry format as the 
simulated model making integration into the anomaly management system relatively 
straightforward. 
 
Figure 4.7 – Biological Prototype Test Bed – The 6-well plate is located to the left 
along with a suite of 1.2 µm syringe filters, heat spreader plates, and optics sensors.  The 
well plate cover is in the foreground along with growth media and the diaphragm pump.  
Valves are located in the middle and supporting electronics are to the right.  A laptop 
(not pictured) continuously logged telemetry for the experiment’s duration. 
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Though the fidelity of the test bed was not that of a precise biological growth 
instrument such as the spacecraft itself, the data required for testing was generated in a 
low-cost yet still effective manner.  For example system noise was always a concern 
when analyzing experimental data, however mitigating these problems in the prototype 
provided valuable lessons learned in preparation for the on-orbit case. 
Execution of the entire hardware experiment was on the order of 72 hours; 
comparable to PharmaSat’s 96 hour duration.  The criteria for the optical sensors were to 
simply detect whether or not a well exhibited growth behavior.  This was made possible 
by reading an analog to digital (A/D) value produced by each well’s corresponding 
photodiode.  Since the changes of these values is subtle as the turbidity of the well 
increased over many hours, occasionally fluctuating values due to voltage noise could 
potentially tamper with actual growth data.  However seeing a downward trend in light 
levels over the course of the experiment was sufficient to detect growth (as the cell 
population grew less light was let through to the photodiode).  To smooth the data the 
same curve fitting approach was used as previously discussed and a negative slope 
threshold was applied for growth determination.  The exact threshold value was 
experimentally determined after having run the experiment several times. 
Three experimental runs were executed with separately induced anomalies for 
each case.  At the conclusion of these experiments, the gathered telemetry was passed 
through the detection and diagnosis algorithms to validate their operation with real 
hardware.  The results from these tested cases are presented in this section.  
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4.3.1 Valve B-2 Failure 
The frail nature of the valves used for the flight unit make them good candidates 
for anomaly validation as seen in this test case.  The pre-experiment failure of the B-2 
valve on the test bed was in fact unintentional and likely occurred during sterilization of 
the fluidic lines or the loading of the biology into the well plates.  As the experiment was 
run it was observed that the B-2 valve did not actuate when required by the state 
machine.  Growth media was pumped through the inactive port in the valve and into the 
waste bag, leaving wells 3 and 4 undosed and the cells sitting in the de-ionized water they 
originally started the experiment in.  Testing of the valve after the experiment concluded 
that a lead had been broken internally thus irreparably damaging the valve.  Telemetry 
gathered from the experiment is shown in Figure 4.8.  A diagram illustrating the anomaly 
is presented in Figure 4.9.  
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Figure 4.8 – Experimental Results for Faulted Valve Condition – 72 hour 
transmittance plots are shown for each well.  Each red line is the fitted regression curve 
used for growth detection.  Note the flat lines of wells 3 and 4 indicating no growth. 
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Figure 4.9 – Valve B-2 Failure – Optical sensors 3 and 4 were flagged as symptomatic 
when no growth was detected in their respective wells.  Constraint relaxation of upstream 
components found only one that could be responsible for wells 3 and 4 to have no growth 
conditions.  The next upstream component is a fluidic line which must have remained 
healthy since wells 5 and 6 were adequately dosed with media. 
 
The recorded temperature telemetry (Figure 4.10) for this experiment was within bounds 
and consequently did not get flagged as hazardous or faulted.  Additionally, the 
configuration of the predicted system model and hardware test bed were consistent 
indicating that the each phase of the experiment had been executed as expected.    
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Figure 4.10 – Nominal Temperature Data – Through the first two phases of the 
experiment as the heater began to warm the sample, temperature constraints were far 
less stringent (± 15°F).  Once the set point temperature was reached and maintained, 
these constraints were narrowed to ± 5°F. 
 
 Passing the experimental telemetry through the anomaly manager generated the 
output shown in Figure 4.11.  Due to the increased complexity of the model, simulation 
execution time for each candidate anomalous component was approximately 34 seconds.  
With a large upstream component list for each symptom there could potentially be a 10-
20 minute wait before the anomaly manager returned any results.  Future work should 
focus on bringing this processing time down by generating a shorter upstream component 
list.  
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Figure 4.11 – Detection and Diagnosis Output, Faulted Valve Case 
Detection Output 
Diagnosis Output 
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The faulted B-2 valve was returned as the only possible candidate after 
approximately 16 minutes of processing time.  In this example the failure of one 
component produced two symptoms, observed from the lack of sample growth in two 
adjacent wells.  The positive identification of the anomaly in a reasonable amount of time 
was an undeniably positive result in the progress of this research project. 
 
 
4.3.2 Fluidic Line Failure 
 
As a second test members of the satellite operations team were asked to introduce 
an anomaly into the test bed.  The rules for anomaly introduction were simple; they were 
allowed to fault any component of the fluidics network, any sensor, or the heater.  They 
were not permitted to introduce a failure into the microcontroller circuit, since it was used 
to log the telemetry needed for diagnosis (on the spacecraft a dramatic failure like this 
would be diagnosed by inspection). 
The anomaly chosen for the test bed was the induced failure of a fluidic line.  
Specifically, the line which was connected to well 6 was physically pulled out of the 
system and pinched to prevent fluid from unnecessarily spilling out of the test bed.  A 
photo of the induced anomaly is illustrated in figure 4.12. 
 
Figure 4.12 – Induced Fluid Line Anomaly – The hose connecting the syringe filter to 
the input port of well 6 was pulled out and pinched to prevent unnecessary leaking. 
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Upon anomaly insertion the experiment was turned on and left to run for 72 
hours.  When data was collected at the end of the experiment, it was run though the 
anomaly manager and the following results were compiled.  It is important to note that 
the telemetry was directly inserted into the anomaly manager with no functional changes 
to remain consistent between test executions.  Most importantly the slope threshold used 
to determine whether or not a well exhibited growth remained unchanged to validate the 
approach for multiple experiments.  Figure 4.13 shows the biology growth over the 
course of the experiment. 
 
Figure 4.13 – Experiment Growth in 72 Hours – All wells exhibit a downward trend 
indicating growth.  Well 6’s trend shows a significantly smaller drop, resulting in a 
calculated slope below the required threshold thus indicating no growth. 
 
These results are a good example of telemetry that an operator may overlook.  Though 
each well exhibits a downward trend and to the casual observer points to positive signs of 
growth, upon closer inspection the downward trend of well 6 is significantly smaller.  
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The initial lower A/D value in well 6 is due to a higher starting cell count while the small 
drop in light transmittance over time is due to cells settling on the bottom of the well and 
blocking the photodetector.  These interpretations need to be reserved for the expert, not 
for the operator.   
 Upon execution of the detection algorithm the optics sensor of well 6 is returned 
as a symptomatic component, since its output was not congruent to the simulation’s 
predicted growth.  The subsequent diagnosis algorithm returned three candidate 
components in approximately 9 minutes.  Figure 4.14 shows this output. 
 
Figure 4.14 – Prototype Anomaly Manager Output – The well 6 optical sensor shows 
a symptom after 36 seconds thus invoking the diagnosis algorithm which offers 3 
anomalous candidates in 9 minutes.  
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The candidates returned in the diagnosis analysis show a single string failure 
somewhere in between the optics sensor and the B-3 valve that did not permit the well 6 
biology to grow.  When traced serially the sensor, well, and fluidic line are all considered 
candidates in preventing growth.  It is left up to the operator to determine (if necessary) 
which one of these components may have not behaved as expected.  Line13 in the model 
represents the well 6 fluidic line and is appropriately listed as one of the anomalous 
candidates.  Figure 4.15 illustrates the anomaly and results returned. 
 
Figure 4.15 – Fluidic Line Failure – The anomaly manager returned the optics sensor, 
well 6, and fluidic line as candidates.  Valve B-3 is not a candidate because well 5 
exhibited positive signs of growth.  
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4.4 PharmaSat Nanosatellite 
 
After development and testing of components, techniques, and algorithms in the 
Simple Model and Biological Prototype, the anomaly management tool was expanded 
and tested with the PharmaSat nanosatellite after its launch on May 19, 2009.  In the 
weeks leading up to the launch the tool underwent final revisions based on test data as the 
spacecraft’s payload was assembled, checked-out, and qualified for the launch and space 
environments.  Testing from both before and after launch helped refine the tool and 
demonstrate its ability to accurately monitor the conditions of a complex payload with 
many components and limited sensing. 
 
4.4.1  Before Launch 
 
Testing before launch helped refine the tool before its integration and use with 
flight data.  The amount of telemetry available to process from these tests was rather 
limited; most of the work done on the payload at this time involved functional checkouts.  
Engineers routinely looked at snapshots of data to confirm a healthy system.  Having 
developed a familiarity with the system in the two years of development leading up to 
these checkouts they knew what telemetry to look for.  This is an example of expert 
system knowledge.        
In the days before delivering the satellite to the launch service provider at 
Wallops Flight Facility the payload was assembled, checked out, and put through a shock 
and vibration test.  Figure 4.15 shows the PharmaSat payload being assembled before 
functional checkouts were performed.   
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Figure 4.15 – PharmaSat Payload Build – An engineer assembling the payload before 
acceptance shock and vibration tests. 
 
 After payload assembly the functional checkout was successful and the spacecraft 
underwent shock and vibrations tests.  After the environmental testing another functional 
checkout was performed.  At this point the engineers observed that three temperature 
sensors were reading abnormally high values.  Further analysis found that the payload’s 
relative humidity had jumped substantially: from 47.3 to 84.9%.  After the team was 
assembled for multiple hours it was decided that a fluid leak had occurred internally and 
the spacecraft had to be disassembled.  Upon further inspection it was found that a fluidic 
bag developed a pin-hole sized leak during the shock and vibration tests – likely due to 
material weakening after the bags were autoclaved for sterilization.  Backup circuitry was 
installed and fluidic bags were replaced.  However, the same autoclaving process that 
produced the weak material in the first bag was also performed with the replacement 
bags.  This meant that a similar leak could develop either during the subsequent shock 
and vibration test or during launch.  Though the spacecraft then passed the final 
acceptance environmental tests, load levels were significantly reduced to prevent 
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damaging the hardware.  Table 4.1 shows telemetry snapshots of three cases; before the 
leak, leak detection, and final payload build. 
 Pre Test Leak Detection Final Build 
TimeStamp (4) 
CardTemp1 (2) 
CardTemp2 (2) 
CardTemp3 (2) 
CardTemp4 (2) 
CardTemp5 (2) 
CardTemp6 (2) 
CardTempM (2) 
FluidicsTemp1 (2) 
FluidicsTemp2 (2) 
FluidicsTemp3 (2) 
FluidicsTempM (2) 
SpareTemp1 (2) 
SpareTemp2 (2) 
Pressure (2) 
RelHum (2) 
RelHumTemp (2) 
Well (1) 
Taos_R (2) 
Taos_G (2) 
Taos_B (2) 
StatusByte (1) 
 
10452979 
2090 
2014 
2104 
2117 
2124 
2083 
2097 
2035 
2083 
2000 
2035 
63038 
63038 
81 
1404 
6059 
16 
15564 
20000 
27397 
4 
 
10546945 
1986 
1910 
2000 
4560 
4560 
4560 
3280 
1945 
1993 
1903 
1945 
63038 
63038 
59 
2700 
5957 
17 
18957 
25974 
27027 
4 
 
9507360 
2028 
2035 
1979 
2028 
2055 
2076 
2031 
2014 
2069 
2021 
2021 
63038 
63038 
82 
944 
6048 
19 
14760 
27972 
20942 
4 
 
 
Table 4.1 – Payload Test Data – Payload telemetry snapshots are shown here before the 
leak, as the leak was detected, and upon the final build of the satellite before delivery.  
The anomalous temperatures read 45.6 °C when the room was clearly near 20 °C.  The 
humidity is shown in ADC counts; after the calibration equation is applied readings are 
47.3, 84.9, and 31.7 % for Pre Test, Leak Detection, and Final Build columns 
respectively.  Applying pressure calibration coefficients shows only a slight increase from 
14.4 to 14.6 psi and back to 14.4 psi for the final build. 
 
These three snapshots were very useful in refining the anomaly management tool.  
After three rounds of testing there existed data which explicitly showed a leak anomaly 
and the behavior of the satellite as a consequence.  With this knowledge and the 
significant possibility of a leak encountered during launch, the detection algorithm was 
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updated with new constraints for the environmental parameters such as temperature, 
pressure, and humidity to verify system health immediately after launch.  Changing the 
model to accurately emulate faulty sensor values due to a leak was out of the scope of 
this project. 
The satellite was successfully delivered and awaited launch for approximately 8 
weeks due to various slips including weather and rocket issues.  Another major factor for 
the experiment was the biocompatibility with the well plate that contained the biology.  
Due to manufacturing processes and material selection, the card was not guaranteed to 
support live samples past 6 weeks of stasis, a significant source of concern for the team.  
Even if the satellite survived launch and deployment, there was a chance that the biology 
would not grow at all.  While the biocompatibility effects were not modeled in the 
anomaly manager (due largely to the lack of characterization in testing), its effects on the 
biology could still be detected though not explicitly diagnosed. 
 
4.4.2   After Launch 
 
Within the first 90 minutes after launch the operations team made beacon contact 
and was able to determine that the spacecraft was at least at first glance healthy.  It was 
not until the following day that data was pulled from the spacecraft and analyzed.  
Though not much data existed beyond basic performance metrics, when run through the 
anomaly management tool a symptom was immediately detected in the relative humidity 
field.  After the leak observed during testing, the spacecraft was sealed with 31.7% 
humidity.  Knowing that the spacecraft was launching into a cold case, humidity was 
raised to 50% as the predicted value set in the simulation and constraint bounds were 
conservatively placed at ±20% humidity.  Figure 4.16 shows humidity data from the start 
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of the experiment as well as the initial constraining bounds.  The output from the 
anomaly management tool that is shown to the user is also displayed.          
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Figure 4.16 – Humidity Hazard Detection – Above: Data from the start of the 
experiment is shown.  Below: A Hazard indicates higher than expected humidity values.   
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The anomaly manager successfully detected this symptom soon after launch 
which persisted through the stabilization (non-heated) phases of the experiment.  Upon 
discussion with spacecraft engineers and managers it was determined that although 
humidity levels were near those experienced at the time of the leak in testing, a leak had 
most likely not occurred.  The reason was that as the hardware sat for several weeks 
waiting to be launched, some fluid had transpired through the porous membranes on the 
well plate and thus contributed to the humidity jump.  Had the spacecraft launched soon 
after integration, the high humidity levels would be a cause for concern; just as the jump 
from 47 to 84% had happened within a matter of a few hours during testing. 
 As expected during the cold case for the spacecraft the humidity kept climbing, 
however when the heaters were enabled the humidity dropped to within the expected 
±20% bounds.  Nevertheless, bounding conditions were altered to +40/-10% for the 
remainder of the experiment and no more humidity-related symptoms existed.  Figure 
4.17 shows humidity data with re-defined constraints.  
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Figure 4.17 – Humidity Bounds Redefined 
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 The humidity bounds scenario was a good example of how MBR attempts to 
capture expected situations in general models.  In this case, the understanding the 
majority of the team had from the test data available was that a leak in the payload would 
be indicated by a higher than expected humidity reading (and possibly more serious 
effects).  However, the experiential knowledge that some team members possessed about 
fluid transpiration through the membrane was not adequately communicated and thus not 
captured in the model.  Though the result was only a false alarm, it highlighted the need 
of thorough knowledge transfer in future missions from team members responsible for all 
subsystems of the spacecraft to model developers. 
 The remainder of environmental telemetry fields stayed within expected 
constraints throughout the duration of the experiment.  Pressures remained constant and 
fluctuated as expected with temperature as the spacecraft transitioned in and out of 
sunlight (Figure 4.18).  Most importantly, there was no rapid depressurization, allowing 
the biology to metabolize oxygen as it grew.           
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Figure 4.18 – Pressure Data 
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Spacecraft temperatures remained within acceptable bounds throughout the 
duration of the experiment.  Fluid temperatures dropped to the lowest tolerable 
temperature of 4.8 °C shortly after launch thus activating the keep-alive heater mode 
which controls to 5°C.  The lower detection bound was set to 4.5°C and was never 
violated.  The upper bound was less of a concern, with the limit set to just shy of what the 
well plate would be controlled to.  Figure 4.19 shows fluidic temperature data for the 
entirety of the experiment. 
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Figure 4.19 – Fluidics Temperature Data – The entirety of the experiment is shown 
here.  Note the lower temperatures during stabilization and the abrupt heating as the 
experiment was commanded to start.  It is interesting to note that once the fluid was 
heated, the fluid heaters were shut off, and heat transfer from the heated well plate kept 
the fluid at a relatively constant temperature.  
 
The well plate’s temperature experienced similar conditions as that of the fluidics 
system with a few occasions of cold trends which required the keep-alive function to 
activate thus preventing the biology from freezing.  Upon experiment execution, the 
temperature quickly rose to its target median temperature of 27 °C.  The median was 
controlled to ±.5°C however due to heat conduction it was expected that temperature 
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sensors around the card vary by approximately ±2 °C.  Therefore these were the 
constraints placed in the detection algorithm.  Since bounds were phase-specific three 
different bounding cases existed as the temperatures stabilized after launch, through the 
heating phase, and finally during active heat control.  Figure 4.20 shows well plate 
temperature data with its respective constraining bounds.    
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Figure 4.20 – Well Plate Temperature Data – Temperature data for the entirety of the 
experiment.  Constraints were based on the experimental phase of the payload and 
changed as heating began, stabilized, and was maintained. 
 
Due to the extended period of time the satellite spent on the launch pad there was 
significant concern over the health of the biology as the experiment had started.  
Biocompatibility issues had forced a 6 week limit to the amount of time biology was 
permitted to remain in stasis.  The eight week stasis condition experienced in the actual 
mission had never been tested, nor could the team replace the well plate with a new one 
given that the satellite was a secondary payload on a rocket that was already stacked and 
awaiting launch. 
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After launch and the experiment had started and ran for approximately 48 hours 
preliminary data was passed through the anomaly management tool.  Regression curves 
were fit to existing growth data and their slopes were calculated and compared to those of 
the modeled system.  It was found that all wells had been successfully fed, which meant 
that the complex fluidic system operated nominally after launch.  At the end of the 96 
hour experiment the data were once again passed through the tool with no anomalous 
effects detected.  It is worth noting that no false positives were identified; the system 
experts (the NASA scientists and engineers) also found no major anomalies after 
analyzing mission data.  Figures 4.21-4.24 show biological data from each dosing case 
after the experiment had completed as well corresponding modeled cases. 
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Figure 4.21 – Control Well Dosing and Growth – Red, Green, and Blue optics values 
are shown respectively as colored points for well 59 in the control bank.  No antifungal 
was administered.  Media dosing is shown by the abrupt change in RGB values. 
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Figure 4.22 – Low Concentration Well Dosing and Growth – RGB values are shown 
for well 48 in the low concentration bank.  As with Figure 4.21, the abrupt initial change 
at around the 70 hour time stamp indicates successful dosing as the well went from being 
generally clear to being filled with Alamar Blue. 
 
 
 
Figure 4.23 – Reference Wells, Real and Simulated – This graphic shows well 36 for 
both real and simulated cases along with the curves’ respective regression curves.  The 
slopes calculated for this case are below the pre-defined threshold indicating no dosing 
or growth.  It is interesting to note that the minor drop in red optics values is an artifact 
of operating temperature and did not affect the dosing and slope threshold calculations.     
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Figure 4.23 shows only one set of simulated reference well telemetry while the 
real data clearly shows three.  This is because only one simulated set is needed to 
compare against all three optics curves.  Had a component failure in the fluidics system 
prevented other wells from growing, they would look like Figure 4.23.  As was seen all 
through ground-based testing, upon successful dosing all three color curves exhibited the 
abrupt slope change shown in the previous figures.  Therefore only one simulated curve 
per well sufficed; its output could be used to make all three color comparisons in each 
well.  Figure 4.24 shows high and medium concentration banks as well as their simulated 
counterparts.   
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(d) 
Figure 4.24 – High/Medium Concentrations and Simulated Wells – Wells 11 (a) and 
24 (b) shown compared to their respective simulated dosed wells (c) and (d). 
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Despite no detected biological symptoms, one set of flat-lined biology data 
existed in a reference well that the anomaly diagnosis tool did not find.  Upon further 
investigation it was determined that one of the reference wells was sacrificed to 
accommodate an extra bolt hole – thus blocking the LED/ detector pair, resulting in zero-
level RGB readings on the optics sensor.  While this did not affect the experiment or the 
anomaly management tool, it once again highlighted the importance of information 
transfer from engineers to model developers and console operators.  Figure 4.25 shows 
the unexpected data.       
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Figure 4.25 – Blocked Reference Bank Well 30 – RGB values are measured at zero 
counts throughout the duration of the experiment.  This is due to the well being sacrificed 
to accommodate an extra bolt, thus blocking the corresponding LED/detector pair on the 
adjacent circuit boards.  This scenario was unanticipated for the model developer and is 
a good example of insufficient knowledge transfer. 
  
As a final check the anomaly management tool analyzed data from the payload 
and fluidics register files searching for possible misconfigurations.  The register file 
entries were compared to those generated in the simulation.  Discrepancies were flagged 
and displayed for the user.  Upon misconfiguration detection the diagnosis algorithm was 
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not invoked – due largely to parameters that were out of the scope of the simulated model 
and that were not immediately tunable on the satellite. 
    Upon execution of the detection algorithm three potential misconfigurations were 
found.  These symptoms are shown to start near phases 4 and 8 (register file telemetry 
was not downloaded for phases 5-7 due to communications blackouts when the orbiting 
experiment was not in range of its ground stations).  Figure 4.26 shows the output 
presented to the user.   
 
Figure 4.26 – Potential Misconfiguration Output  
 
The three potential symptoms were heater off states during the experiment for 
both the fluidics and well plate.  Lastly the heat stability flag for the well plate only 
activated briefly a few times.  The heat stability software flag was set when three 
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consecutive temperature readings were within ±.5 °C of the set point.  These potential 
anomalies have significant implications – for example heater off states and an inability to 
maintain temperature control during the biology’s growth phases can be mission-critical.  
In this case these warnings were just that; there were no detected hazards associated with 
the payload indicating that the temperatures were all within expected bounds.  To 
reassure themselves the operators could then manually inspect temperature data to find 
that heating had occurred nominally. 
An explanation for the card heater off state is that the temperature had overshot its 
set point and was turned off by the microcontroller.  This also explains the card stability 
flag not always being set.  If the temperature is oscillating beyond its ±.5 °C tolerance 
three consecutive readings within the bounds becomes less likely.  If anything, this 
suggests that perhaps a better thermal control strategy be used in future missions besides 
the “bang-bang” on/off scheme employed on PharmaSat to dampen the oscillations. 
While these explanations may also be valid for the fluidics heater state, upon 
closer inspection it was noticed that a heater ‘on’ flag had never been set throughout the 
experiment, though clearly the temperature profiles indicated that the heater operated 
nominally.  Certainly a possibility is that a register file with this flag set high was not 
downloaded during the phases that fluidic heating was occurring, however the other 
possibility is that there was a bug in the software and the flag never got set.  Though the 
first possibility is most likely, due to compressed development schedules and limited 
testing the second case cannot be completely ruled out.  Model-based tools such as the 
one developed in this research can be used not only in operational scenarios but can also 
aid in finding unexpected anomalies through the project’s development phase. 
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The PharmaSat nanosatellite successfully completed its mission 2 weeks after 
launch when primary operations had concluded and stored experimental data had been 
downloaded from the satellite. 
 
4.5 Results Summary 
 
The experimental results shown in this chapter validate the use of MBR on a 
biological system as a decision support tool.  Through the experimentation conducted 
both in simulation and with hardware in the loop on the ground and in space, the 
approach intended for use with biological spacecraft payloads is shown to be valid.  In 
the case of prototype ground test hardware failures, one artificially injected into the 
system and one unintentional, the anomaly manager detected the anomaly and offered a 
list of possible components responsible for the failure.  For the valve failure case, only 
one component was returned as the logical culprit, while the failed growth case was 
narrowed to 3 candidates. Though the spacecraft operated nominally, several warning 
conditions provided further insight into the operations of the MBR tool and the satellite 
itself.    
While processing times increased with system complexity, they are still within 
acceptable bounds given the mission operations scenario of only needing to diagnose 
anomalies near real-time.  Some level of system knowledge was necessary to understand 
the candidate list; however a high level understanding was sufficient.  
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5. Conclusions 
 
This chapter summarizes the research presented in this thesis.  Additionally a 
roadmap for future work is laid out referring to upcoming heritage-based biological 
payload spacecraft currently in development.  Finally, lessons learned are discussed to aid 
in future anomaly management research. 
 
5.1 Summary 
The objective of this thesis was to demonstrate the feasibility of using model-
based reasoning techniques as an aid to a human operator for detecting and diagnosing 
possible anomalies in the biological payload of a spacecraft.  An existing graphical 
modeling environment was extended through the creation of new component blocks that 
can now accommodate factors such as fluid flow and biological growth.  The nature of 
the modeling scheme is such that these behaviors can be applied to any engineering 
system, not just a biological incubation instrument.  Additionally, this research continued 
to standardize the MATLAB and Simulink software packages for development of 
reusable models and component blocks for anomaly management applications.  Finally 
this research also includes (to the author’s knowledge) the first use of MBR with the 
biological payload of a spacecraft. 
  
5.2 Lessons Learned 
The Model-Based Reasoning technique is very effective in compiling in-depth 
design knowledge from many subsystems to characterize a system’s behavior and 
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accurately diagnose anomalous events.  The ability of this system to reason on telemetry 
generated by an engineering system aids the user in developing a gut feel for advanced 
teleproprioception.  
It is important to note that the time spent developing this tool was extensive; it is 
clear why many industries may not immediately strive to use this approach for their 
particular applications.  Experts who have worked on different aspects of the design and 
development can suffice for anomaly diagnosis if they are available.  Since the anomaly 
manager will reduce the time it takes for a possible diagnosis, opting to not use such a 
system involves a trade between development time and cost versus diagnosing time spent 
on ‘manual’ anomaly resolution.  For some engineering applications, the upfront 
investment of developing an anomaly management system may save money during 
operations when time is a critical factor in anomaly resolution.  An example would be 
trying to minimize the downtime of an assembly line process by using the anomaly 
manager to narrow down a list of candidate components which may be faulted, 
misconfigured, or operating out of expected bounds. 
One suggestion for future development of anomaly managers would be to design 
them in parallel with the actual system.  Building both the model and real system 
concurrently offers a unique way of embedding design knowledge into the model, and 
lessons learned from simulation modeling can positively impact the design of the real 
system.   
A lesson to learn from concurrent model development is observability.  When 
modeling sensors and generating simulated telemetry an evaluation should be performed 
as to whether or not anomalies are easily detected in the current design.  If they are not 
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observable with respect to the anomaly manager, they will not be observable in the real 
system.  In this way, concurrent model development will aid the design of the actual 
system, where design iterations can be performed to either embed more sensing or force a 
system redesign so as to yield definitive answers for when a component operates 
anomalously.      
Lastly, a heavy importance must be placed on ease of use; the operator should not 
need to have expert knowledge of the anomaly manager to be able to run it.  Intuitive user 
interfaces should be just as important to develop as the system model itself. 
These lessons learned were important in the development of this research tool and 
will aid in future implementations as more systems are evaluated and modeled.  The 
experimental results as well as the use of this system on the PharmaSat flight experiment 
were valuable in demonstrating the usefulness of MBR research and unquestionably 
justify continued investigations into this field. 
 
5.3 Future Work 
With the objectives listed in Chapter 1 completed, the short term focus for future 
work should be for continued verification and refinement of this decision aid tool as it is 
modified and adapted for use in mission operations.  Running the anomaly manager on 
ground data and comparing to flight results could yield insights into microgravity effects. 
Other tasks include the ability to simulate anomalies mid-experimental phase and to only 
simulate a subset of all phases to reduce processing time.  Incorporating reduction 
algorithms to upstream candidate lists will also speed up the diagnosis process. 
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A significant amount of time can be spent on trying different approaches to 
qualitatively measure the behavior of the biological experiment over time.  This may 
include a departure entirely from curve fitting, derivatives, and thresholding.  Higher 
fidelity models can have variables that include higher antifungal concentrations, 
contamination, evaporation, depressurization, and subtle temperature effects.  Ultimately 
a trade needs to be considered for the effort to incorporate higher fidelity modeling vs. 
the increased development time and the gain that this effort will bring to the project. 
Other interesting additions to this research can involve more comprehensive 
modeling by ways of anomalously created structural connections.  The example presented 
in Chapter 4 discussing temperature sensor anomalies caused by a fluid leak highlighted 
the need for dynamically generated connections which may add to the fidelity of a 
modeled anomaly.  Likewise, having the ability to explicitly control simulated 
configurations would allow misconfiguration states to be included in the diagnosis 
algorithm rather than being left for inspection by the human upon detection.    
For the longer term this research needs to be expanded to the application of 
PharmaSat’s follow-on missions such as O/OREOS (Organism/ ORganics Exposure to 
Orbital Stresses), launched on November 19, 2010.  Developed by the same group at 
NASA Ames Research Center, this nanosatellite has two separate biological experiments 
aimed at studying the effects of microgravity and radiation on biological strains as well as 
organic samples.  Though the chassis and bus were essentially re-flights of GeneSat-1 
and PharmaSat, a higher altitude, inclination, and required 6 month mission lifespan will 
elevate the spacecraft’s radiation doses – a condition not yet experienced on this family 
of nanosatellites.  With Santa Clara University performing ground operations for this 
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mission, the need to characterize possible anomalous behaviors of the bus and payloads is 
of high importance for timely diagnosing and resolving actions.  Though already 
launched, the opportunity to implement an anomaly manager for this satellite is a viable 
short-term goal. 
Upcoming missions such as ECAMSat, MisST, and SporeSat would also benefit 
from a similar anomaly management system.  Each of these experiments is unique and 
carries potential risks that could lead to anomalous behavior possibly jeopardizing the 
mission.  The use of an anomaly management system could help lower the risk of 
operating the spacecraft with an undetected or poorly characterized anomaly.  
Adaptations of the system developed for this thesis concentrate on the mission operator 
as the decision-maker when anomalies are detected and diagnosed.  Further in the future 
the application of onboard anomaly management with automated resolving actions could 
ultimately lower the risk that is inherently carried in small satellite applications with little 
to no redundancy.  The trade for this more immediate resolving capability is of course the 
extensive development time required to adequately validate and verify the system will 
perform adequately without posing significant risks to the spacecraft.   
The application of this research to a multitude of other engineering systems is 
possible thanks to a concretely laid out theoretical framework built into a modular and 
adaptable graphical environment.  However currently this framework does not 
necessarily extend to model development itself, therefore the creation of steps a 
developer can take to abstract system behaviors and parameters into a hybrid model such 
as the one presented in this thesis would help streamline the production of future MBR 
research platforms. 
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Appendix 
 
A.1 – PharmaSat Fluidics Network Diagram 
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Simulink PharmaSat Payload Model 
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A.T.1 – PharmaSat State Machine 
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A.2 – Biological Prototype Documentation 
 
 
Phase Pump V1 V2 V3 V4 Heater 
Duration 
(sec) 
1.)  Periodic Recirculate X    X  TBD 
*Until Start Expr. Button        
2.)  Periodic Recirculate X    X X TBD 
*Until Heat Condition Met      X  
3.)  Dose Banks 1-2 X X    X 10 
4.)  Dose Banks 3-4 X  X   X 10 
5.)  Dose Banks 5-6 X   X  X 10 
6.)  Diffusion Time Allowance      X 60 min 
7.)  Dose Banks 1-2 X X    X 10 
8.)  Dose Banks 3-4 X  X   X 10 
9.)  Dose Banks 5-6 X   X  X 10 
10.) Growth Time Allowance 
*Optics and Heat Control 
Active 
*Fluidics Park and Shutdown      X 40 hrs 
Table A.2.1 – Prototype Experiment State Conditions – Each sub phase is illustrated 
in this table with corresponding component actuation indicated by an ‘X’ and 
corresponding time duration. A blank box indicates an ‘off’ state.  
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A.3 – Functional Component Models 
      
One of the major goals of this research project was to create reusable component 
blocks which could be used in the modeling of a variety of biological payload designs in 
a spacecraft not only for the PharmaSat mission but follow-on missions with similar 
experimental layouts.  As discussed in Chapter 2, the main components of the biological 
experiment consists of pumps, valves, fluidic lines, specimen wells, media bags, heaters, 
sensors, microcontrollers, and a number of passive components.  The modeling of these 
components is shown here, their implementation in the system model is shown in Figure 
A.1, and their usage in the model is discussed in the subsequent section.   
The microprocessor (Figure A.3.1) in the model simulated functionality of both 
PICs in the PharmaSat payload and both BASIC Stamps in the biological prototype.  This 
was done as a way to simplify an already complex model while still offering the state-
machine event-based actuation required for the experiment’s components.  Additionally, 
the use of two microcontrollers on these systems was selected based on individual 
memory allocation limitations; these were not issues with the MATLAB simulation.  The 
modeled controllers emulating the PharmaSat and prototype experiments were configured 
slightly differently based on the number of components actuated and phases executed, but 
their overall behavior remained analogous. 
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(a) Masked View 
 
(b) – Unmasked View 
 
Figure A.3.1 – The Modeled Microcontroller – (a) - The view offered to the user.  The 
desired phase of simulation can be directly manipulated.  (b) – Control outputs shown 
going to the model’s actuated components.  
  
This component was responsible for maintaining the modeled phase of the 
experiment by means of heater set points for the fluidics network and the well plate (tasks 
handled by the payload processor in the real system) as well as the actuation of 2 pumps 
and 13 valves (given to the fluidics processor).  The user is able to select specifically 
which phase of the experiment they would like to execute.  Entering a ‘0’ will 
sequentially execute all phases.  The experimental phases are modeled after the state 
diagrams in appendix A.T.1 and are further discussed in Chapter 3.5.   
Rather than directly connecting fluidic components together in the system model, 
blocks representing the Tygon tubing used in the actual system were created as a way of 
not only modeling the fluid flow with more fidelity, but as a way of calculating dilution 
concentrations throughout the fluidic network.  These tubes were responsible for passing 
fluidic information through while calculating and updating their volumetric dilution ratio 
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of growth media to antifungal solutions.  The antifungal concentration is simply defined 
as:  
concentration = (volume of antifungal)/ (volume of growth media + antifungal) 
The updated concentration therefore is based on the equation: 
 
updated concentration = ((current concentration)*(line volume) + (pumped 
concentration)* (pumped volume))/ (pumped volume + line volume) 
 
The fluidic state of the line is then updated with the new concentration value and the 
volume is assumed to remain the same (i.e. no bubbles or inconsistencies) with the excess 
pumped to the next component along with an updated concentration value.  The volume 
of the fluidic line is defined in the block parameters dialog box and additionally accounts 
for hold-up volumes of the valves and pumps connected to the lines.  This is done since 
these components are only modeled to direct fluid flow signals.  Figure A.3.2 shows the 
model block with its corresponding dialog parameter box. 
 
 
 
 
 
(a) – The Fluidic Line Model Block 
 
(b) – Fluidic Line Block Parameter Box 
Figure A.3.2 – The Fluidic Line Block Model 
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 Media and waste reservoirs act similarly to fluidic lines in the sense of monitoring 
fluid volumes and concentrations.  The main difference is that their volume is not 
assumed to be static – rather it is constantly recalculated based on its inputs and outputs.  
The concentration in the bag is also recalculated and updated in the simulation.  Figure 
A.3.3 shows both types of reservoirs; one dedicated to holding experimental media and 
one used to collect waste fluids.   
 
(a) – Antifungal Media Bag 
 
(b) – Large Waste Bag 
 
Figure A.3.3 – Media and Waste Bag Models 
 
The valve models were created to emulate the functionality of those used in 
PharmaSat and the biological test bed prototype.  In same way the real solenoid valves 
route fluid to the NC or NO port from the common port based on an applied voltage, the 
modeled block routed data to one port or the other in much the same way based on a logic 
1 or 0 signal.  In the PharmaSat system, the same valves were implemented in two 
fashions; A-type valves had a sealed NO port, essentially acting only as ON/OFF valves 
with the one remaining port, while B-type valves remained unmodified.  These behaviors 
were accounted for in the modeling, and Figure A.3.4 shows both types of model blocks.  
The valves were additionally given environmental parameters such as temperature and 
pressure constraints.  To aid the user the foreground color of the block is programmed to 
change from blue to red when actuated so as to help oversee correct execution.   
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Figure A.3.4 – Modeled A-Type and B-Type Valves - The microcontroller sends a 1 or 
0 signal to (a) making the valve route the modeled fluid flow from (b) to (c) or (e) in the 
case of a B valve, and from (b) to (c) or no flow in the case of an A valve.  Requested 
volume paths exist for each line shown in (d). 
 
The stepper pump model (P2 in PharmaSat component nomenclature, Figure 
A.3.5) is designed to dispense metered quantities of media through the simulation based 
on desired inputs from the microcontroller.  Each step of the motor dispenses .1 µL of 
media based on the pump’s piston throw.  The motor can be stepped in both directions 
which either aspirates fluid into the pump cylinder or dispenses the fluid out into the 
network.  
 
(a) – Masked View 
 
(b) – Unmasked View 
 
Figure A.3.5 – Modeled Stepper Pump 
 
 The frequency that the motor is stepped at corresponds to the speed at which the 
piston is moved, but has no effect on the volume dispensed.  Only the amount of steps 
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taken in a given direction governs this, so even though the desired frequency is passed to 
the pump model this value is not immediately considered.  The control signal itself is a 
vector of double precision digits with the following format:  
P2_state = [P2_direction P2_frequency P2_steps] 
P2_direction can be [0, 1, 2] making the pump stop, dispense, or aspirate respectively.  
P2_frequency and P2_steps are based on the desired pump frequency and step quantity 
specified in Appendix Table A.T.1.  The working volume is calculated by multiplying the 
number of steps by .1 to convert into µL.  To prime the piston cylinder, aspiration is 
always done first.  When aspirating, the pump draws fluid into its chamber, therefore 
propagating the required volume value back to the appropriate media reservoir (based on 
corresponding valve states) and remains in standby until this value is passed back into the 
pump.  With the virtual cylinder primed the stepper pump is ready to dispense. When the 
dispense command is given by the microcontroller this volume is propagated around the 
components of the fluidic network.  One aspiration/ dispensation iteration is discussed in 
Figure A.3.6.   
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Figure A.3.6 – Stepper Pump Progression – Once a control vector has been sent to the 
pump the required aspirated volume is computed and sent from (a).  It passively flows 
through (b) and into valve B4.  B4’s common port is connected to the stepper pump while 
its NO port leads to the Antifungal bag (a red valve block would indicate a NC port 
connection to the Dilution bag). The required volume is therefore also passed out the NO 
port down (c) and (d) where the Antifungal Bag dispenses this amount and updates its 
volume and concentration values.  This dispensed volume flows through (e), (f), (g), and 
(h) while updating concentrations in the fluid lines along the way.  Having reached the 
pump, the volume is primed and dispensed upon acquisition of the appropriate ‘dispense’ 
control vector.        
 
The growth of the simulated biology is a function of such parameters as 
temperature, pressure, humidity, and growth media.  To aid in some system simulations, a 
growth curve model was developed using regression models based off of the GeneSat-1 
experiment’s E. coli optical density curves.  As discussed in Chapter 1, the modeling of 
Saccharomyces cerevisiae for the PharmaSat experiment can be done on an in depth 
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scale; however the sensing of many growth attributes is required for proper model 
verification.  These experiments contained a different kind of sensing which did not allow 
for this nature of modeling.  Rather, in the model used for this research the biology 
growth curves were fitted to polynomial trend lines.  These trend lines were then passed 
through a number of scripts for interpretation with the goal of detection and diagnosis of 
anomalous growth attributes.   
The simulated biology growth was directly incorporated into the well plate blocks 
with corresponding temperature sensors, and optics detectors.  Each well contained its 
own regression-based biological curve, along with a running calculation of volume and 
concentration of growth media/ antifungal administered.  The curves were then generated 
based on these values.  The output of the wells then was picked off by the temperature 
and optics sensors which passed the data to a telemetry file writer.  A heater driven by the 
microcontroller set the temperature of the well plate and fluidics based on which phase 
the experiment was undergoing.  Figure A.3.7 shows a simple one-well setup and its 
associated simulated telemetry plot.  Additionally each of the sensors was configured for 
possible anomalous states.  
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Figure A.3.7 – Biological Well Model 
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 After all system telemetry was generated, the values were passed to a function 
block responsible for writing data to a text file.  This text file would then be loaded and 
interpreted once detection and diagnosis were executed.  The telemetry writer block 
contained two modes: sim_telem and eval_telem.  When in sim_telem mode the text file’s 
output was set to be named “sim_telemetry.txt” which represented simulated telemetry in 
nominal operation.  This data was used for comparisons with that of the real system to 
find symptoms.  Upon symptom detection and model reevaluation subsequent telemetry 
entries would be written to “eval_telemetry.txt” under eval_telem mode.  This was done 
so as to preserve sim_telemetry.txt without deleting or overwriting it (useful for running 
the tool multiple times).  Figure A.3.9 shows the telemetry writing block. 
 
Figure A.3.8– Telemetry Writing Block 
